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Summary 
The brain belongs to the most fascinating organs that developed in evolution. Its 
complexity is responsible for recording and organizing impressions from the environment, 
for our thoughts and feelings, for our personality. Knowledge of the mechanisms involved 
in the development of the brain, in thinking and transmission of neural signals is likely to 
also help our understanding of disease mechanisms underlying Alzheimer’s and 
Parkinson’s disease or neuromuscular diseases including muscular dystrophies. 
The brain is a complex network of billions of neurons and supporting cells. Ramòn Y Cajal 
showed in the 19th century with the Golgi-technique that each neuron is a unit that 
communicates with other neurons by special contacts called synapses (Cajal, 1928). Most 
of our current knowledge of how synapses work and of how they develop derives from our 
profound understanding of the neuromuscular junction (NMJ), which is relatively simply 
structured and organized. The key regulator for the development and maintenance of the 
NMJ is the highly glycosylated heparansulfate proteoglycan (HSPG) agrin. Owing to 
alternative first exon usage, agrin can be expressed in a secreted form (SS-NtA-Agrin) or a 
transmembrane form (TM-Agrin). The amino-terminus of SS-NtA-Agrin binds to the 
extracellular matrix (ECM) via laminin. That of TM-Agrin consists of a short intracellular 
and a transmembrane region. TM-Agrin is preferentially expressed in the CNS, particularly 
by neurons of the brain (Neumann et al., 2001). 
This thesis examines the function of TM-Agrin in non-neuronal and neuronal cells. Using 
transfection of cDNAs encoding full-length TM-Agrin, chimeric constructs and mutants 
thereof, I show that TM-Agrin has a strong effect on cell morphology. In particular, during 
my research, cells expressing TM-Agrin formed long and numerous actin-containing 
microprocesses. In the chimeric constructs I replaced the intracellular part, the extracellular 
part or the TM-domain of TM-Agrin with a corresponding part of another TM-protein. In 
the mutant the glycosaminoglycan (GAG)-attachment site between the 7th and 8th
follistatin-like (FS) domain was mutated so that sugar chain could not attach. By this 
means I managed to elucidate that the described effect is dependent on the close 
association of the extracellular part of TM-Agrin with the membrane and, additionally, on 
the presence of the GAG-chain localized between the 7th and 8th FS domain. 
To evaluate whether similar effects of TM-Agrin can also be observed in neuronal cells, 
we also transfected primary hippocampal mouse neurons. Indeed, transfected neurons 
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showed a curvy growth and developed microspikes on axons and dendrites indicating that 
TM-Agrin also affects neuritogenesis. To test whether these effects could be based on 
overexpression-induced self-dimerization of TM-Agrin, and whether TM-Agrin could 
directly activate a signalling cascade, we also used antibody-induced dimerization, a 
method that has been shown to allow activation of single transmembrane domain receptors 
(Heldin, 1995; Weiss and Schlessinger, 1998). Indeed anti-agrin antibodies induced dose- 
and time-dependent formation of microspikes on primary mouse hippocampal neurons, 
suggesting that TM-Agrin may have a function in inducing the reorganization of the actin-
cytoskeleton and also in development of neurites and their outgrowth. 
In the last part of the work we created a transgenic mouse in which the expression of a 
miniaturized version of mouse neural agrin could be temporally controlled. In Duchenne 
muscular dystrophy (DMD), dystrophin has mutated, which leads to fragility of muscle 
membranes to cause muscle wasting. It had been shown that overexpression of utrophin, an 
autosomal homologue of dystrophin can functionally compensate for the loss of 
dystrophin. With this mouse model we tested whether overexpression of agrin also causes 
upregulation of utrophin in vivo. This could be an appropriate way to ameliorate and 
eventually also cure DMD. 
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Abbreviations 
A alanine 
aa amino acid 
AB antibody 
AChE acetylcholine esterase 
AChR acetylcholine receptor 
APC antigen presenting cells 
ASGP-R asialoglycoprotein receptor 
BAC Bacterial Artificial Chromosome 
BBB blood-brain barrier 
BSA bovine serum albumin 
CNS central nervous system 
DAP dystrophin-associated proteins 
DIV days in vitro 
DMD Duchenne muscular dystrophy 
E embryonic day of development 
ECD  extracellular domain 
ECM extracellular matrix 
FCS fetal calf serum 
FS follistatin like 
GABDH glyceraldehyde3-phosphate dehydrogenase  
GAG glycosaminoglycan 
GAM goat anti-mouse 
GAR goat anti-rabbit 
HEK human embryonic kidney cells 
HoS horse serum 
HSPG heparan sulphate proteoglycan 
IS immunological synapse 
kb kilobase 
kDa kilodalton 
LG laminin G-like 
Abbreviations 7 
MHC-p histocompatibility-peptide complexe 
MuSK rat homologue of the muscle specific kinase (nowadays used for all 
species) 
NBM neurobasal medium 
NCAM neural adhesion molecule 
NGF neural growth factor 
NGS normal goat serum 
NMJ neuromuscular junction 
NP nanopure 
Nsk2 mouse homologue of the muscle specific kinase 
(old nomenclature) 
NtA N-terminal of agrin 
oN overnight 
P/S penicillin/streptomycin 
PBS phosphate-buffered saline 
PCR polymerase chain reaction 
PFA paraformaldehyde 
PNS peripheral nervous system 
RT room temperature 
S serine 
S/T serine-threonine rich 
SG serine-glycine 
TM transmembrane domain 
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Chapter I 
General Introduction 
The Synapse 
The word ‘synapse’ derives from Greek ‘synaptein’ (‘syn’ meaning ‘together’ and 
‘haptein’ meaning ‘fasten). First described for neurons, synapses form a highly specialized 
structure to guarantee a rapid and precise communication between neurons and their target 
cells. These junctions are responsible for the precise transformation of information from 
the pre- to the postsynaptic cell. The information is relayed by directed secretion of 
neurotransmitters. Most vertebrate synapses are activated by an action potential that lead to 
a subsequent Ca2+ influx in the presynaptic terminal. This results in fusion of vesicles with 
the nerve membrane and the neurotransmitter release into the synaptic cleft. The 
neurotransmitter diffuses and binds to specific receptors in the postsynaptic membrane. 
The postsynaptic membrane potential changes and can trigger the propagation of the action 
potential. During synaptogenesis, synapses form, mature, and stabilize and are also 
eliminated by a process that requires intimate communication between pre- and 
postsynaptic partners. Most of our understanding of synapse formation, maturation and 
stabilization comes from extensive studies on the neuromuscular junction (NMJ). The NMJ 
describes the close contact and interaction between motor neuron and the target muscle 
cell. Three most widely appreciated experimental advantages, its large size, its relative 
simplicity and unparalleled accessibility make this type of synapse a suitable model for 
understanding synapse development and function (Sanes and Lichtman, 1999). 
Most of our knowledge and understanding about synapse formation, stabilization and 
function in the CNS derives from intensive studies of vertebrate NMJ. Recent advantages 
in methodologies, including real-time imaging of living neurons, allow a deeper insight 
into the molecular, cellular, and activity-dependent processes that guide synaptogenesis in 
the developing CNS. But nevertheless there are still many open questions. 
The immune system also developed an elaborate system of cell-cell communication. The 
immunological synapse (IS) describes the direct contact between T-cells and the antigen 
presenting cells (APCs). Roaming through the body, APCs (e.g. dendritic cells, B cells or 
activated macrophages) capture and ingest infectious microbes. The pieces of their cut 
proteins (antigens) are displayed on their surfaces. These antigens, also called major 
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histocompatibility-peptide complexes (MHC-p), are inspected by the immune system's T 
lymphocytes, which decide whether to mount an antigen-specific immune response to the 
invader. 
 
A  B   C  
 
Fig. 1: Pictures NMJ, synapse in brain and immunological synapse 
(A) A whole-mount view of neuromuscular synapses in rat soleus muscle. Nerve branches from presynaptic motor neurons and the 
postsynaptic muscle fibers were visualized with antibodies against laminin α2 (red). Postsynaptic AChRs (green or yellow) accumulate 
at the neuromuscular junctions. (B) At the immunological synapse, the T-cell receptor–CD3 complex (red) and agrin (green) aggregate 
at the site of contact between an antigen-presenting cell (APC) and an activated T cell (yellow). (C) Primary neurons stained at 20.day in 
vitro (DIV) for TM-Agrin (red), for the dendritic marker MAP2 (blue) and for the presynaptic marker Synaptophysin (green). 
Scale bar in A is 50 µm, in B 10 µm and in C 50 µm. Note the marked differences in synapse number and size among the tissues. 
(A and B from Bezakova et al., 2003) 
 
Agrin 
During the last decades significant efforts have been made to understand the formation, 
structure and function of the postsynaptic apparatus. One of the important findings has 
been that the formation and stabilization of the postsynaptic structure is dependent on 
molecules provided by the axon (for review see Dennis, 1981). Later studies have shown 
that agrin is such a molecule. This protein was first discovered and purified from basal 
lamina containing extracts of the electric organ of the marine ray Torpedo californica 
(Godfrey et al., 1984). Basal lamina-containing extracts showed AChR- and AChE-
aggregating activity when added to myotubes (Godfrey et al., 1984; Nitkin et al., 1987; 
Magill-Solc and McMahan, 1988). This aggregating factor was then called “agrin”, which 
derives from the Greek ‘agrein’, meaning ‘assemble’. This highly glycosylated 
heparansulfate proteoglycan (HSPG) protein is a key organizer of postsynaptic structure of 
the NMJ (Ruegg and Bixby, 1998). Agrin also has an important role in presynaptic 
differentiation because it acts as a stop signal for motor neurons (Campagna et al., 1995; 
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Campagna et al., 1997). Later findings also provide evidence that the activity of agrin may 
not be restricted to the NMJ. The protein is also highly expressed in the CNS (Rupp et al., 
1991; Burgess et al., 2000; Neumann et al., 2001; Kroger und Schroder, 2002). 
Additionally, agrin was found at the immunological synapse (Khan et al., 2001). 
Thus agrin plays a crucial and well understood role at the NMJ, but its activities in the 
CNS might be of broader significance than previously assumed. 
 
The Agrin Gene 
Alternative splicing of the agrin cDNA generates agrin proteins that differ in their 
distribution and function (for review see Bezakova and Ruegg, 2003). The 3'end is very 
well characterized and highly conserved. Splice sites at the 3'end, called A and B (y and z 
in rodents), have a strong influence on the biological activity of agrin (Ruegg et al., 1992; 
Ferns et al., 1993). Splice site A contains 0 or 4 amino acids (aas); site B includes 0, 8, 11 
or 19 aas (Ruegg et al., 1992; Rupp et al., 1992a). Only those splice variants containing 
amino acid inserts are active in inducing AChR clustering and are essential for the 
development of the NMJ. Inserts at B/z site are crucial for agrin-induced postsynapse-
inducing activity in vivo (Ruegg et al., 1992; Burgess et al., 1999). 
Isoforms with B/z inserts are expressed by motor neurons and are referred to as “active”. 
Those that lack aa inserts are expressed by the muscle fibers and are inactive in AChR 
clustering. 
 
Fig. 2: 5'end of mouse agrin gene encodes two different amino-termini 
Both agrin isoforms, the secreted protein SS-NtA-Agrin and the transmembrane protein typeII TM-Agrin, are expressed from the same 
gene. The sequence of NtA (N-terminus of agrin) is encoded by two exons and that of the N-terminus of TM-Agrin by only one. 
Alternative first exon usage results in the two different forms and is indicated by continuous line and broken line respectively. 
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In addition, alternative first exon usage results in the synthesis of two alternative amino-
termini. The agrin gene therefore codes for a secreted protein (SS-NtA-Agrin) and for a 
typeII transmembrane protein (TM-Agrin; Burgess et al. 2000; Neumann et al., 2001). 
 
The Agrin Structure 
The highly glycosylated heparansulfate proteoglycan agrin is differentially localized and 
strongly alters its function owing to alternative splicing and alternative first exon usage. 
At the amino-terminus SS-NtA-Agrin includes a short signal sequence, which is cleaved so 
that the protein can be secreted. This domain is highly conserved among species. A start 
methionine is located in the KOZAK sequence (Kozak et al., 1986). The NtA domain 
contains a laminin binding site, which is crucial for the binding to the γ 1-chains of 
laminins and thus for the immobilization of agrin in the basal lamina (Denzer et al., 1995; 
Denzer et al., 1997). A splice site at the 5'end that includes a 7-aa-long insert has also been 
found in chicken. This splice variant has a decreased affinity to laminin (Denzer et al., 
1997). 
TM-Agrin contains a short, not conserved cytoplasmic part and a transmembrane domain 
that is conserved among species and converts agrin to a typeII transmembrane protein and 
localizes the protein in an Ncyto/Cexo orientation in the plasma membrane (Neumann et al., 
2001). 
 
 
Fig. 3: Agrin domains of the secreted and of the transmembrane protein 
When the protein is secreted, the signal sequence is cleaved. The SS-NtA-Agrin has a laminin-binding site which is essential for the 
binding of agrin to the basal lamina. This site is absent in TM-Agrin. This isoform is inserted in the plasmamembrane. It has a short 
cytoplasmic part and a transmembrane domain that shows high homology across species. 
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The following domains are attached to the amino-terminus: 
FS
 Follistatin-like domains (FS) 
A conserved glycosaminoglycan (GAG) chain attachment site is localized 
between the 7th and the 8th FS domain. 
LELE
 Laminin-EGF-like domains (LE) 
One of such domains in the laminin γ1-chain binds nidogen. LE domains in 
agrin do not bind to nidogen. 
S/T
 Serine/Threonine-rich domains (S/T) 
The first S/T domain carries 2 GAG chains. 
SEA
 Sea urchin, enterokinase, agrin domains (SEA) 
This domain was first found in a sea urchin sperm protein, in enterokinase 
and in agrin. 
EGEG
 EGF-like domains (EG) 
These regions are characterized by a motif of 6 regularly spaced cysteine 
residues linked via disulfide bridges. 
LG
 Laminin G-like domains (LG) 
Two of these domains contain the A/y and B/z splice sites, which are 
characteristic for the nerve- or the muscle-derived agrin isoforms. 
 
The agrin gene encodes in all species a protein with more than 2000 aas with a predicted 
mass of 225kDa. On SDS-PAGE the protein shows a diffuse band of about 400-600kDa. 
Further studies have shown that agrin is a heparan sulfate proteoglycan (Tsen et al., 
1995b). Glycosaminoglycan (GAG) attachment sites are localized to two locations within 
the agrin molecule. One site is localized between the 7th and 8th FS-domain. Three closely 
spaced serine-glycine (SG) clusters carry exclusively heparansulfate chains. The second 
GAG attachment site is positioned in the centrally located S/T-domain and contains a 
cluster of four closely packed SG consensus sequences. In contrast to the first GAG 
attachment site, the second carries mostly chondroitin sulfate side chains. Agrin exhibits 
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mixed glycosylation patterns so that agrin is not only a heparansulfate but also a 
chondroitin sulfate proteoglycan (Winzen et al., 2003). 
 
Agrin at the Neuromuscular Junction 
Several lines of evidence have led to the ‘agrin hypothesis’ (McMahan, 1990) that 
postulates that the heparansulfate proteoglycan agrin is synthesized in motor neurons and 
transported along the axons to the muscles where it is secreted into the synaptic cleft. 
There it binds to a still unknown agrin receptor on the myotube surface and causes 
acetylcholine receptors (AChRs), acetylcholinesterase (AChE) and proteins of the 
postsynaptic apparatus to aggregate. Agrin was then molecularly cloned from mammals 
and birds (Rupp et al., 1991; Tsim et al., 1992). The ‘agrin-hypothesis’ was confirmed by 
numerous independent groups and this gave rise to a much deeper understanding on 
mechanisms involved in formation and maintenance of NMJ (Gautam et al., 1996; 
DeChiara et al., 1996; Glass et al., 1996). The crucial role of agrin for synaptogenesis 
became obvious. 
 
Agrin Affects the Pre- and Postsynaptic Differentiation at the NMJ 
The NMJ is a precisely organized structure that is composed of the presynaptic nerve 
terminal of the motor neuron, the postsynaptic muscle cell and the Schwann cell. 
Prior to innervation AChRs are freely diffusible and randomly distributed in the muscle 
cell plasma membrane and at a low density (∼1000/ µm2). The active isoform of agrin, also 
called neural agrin (for review see Ruegg and Bixby, 1998) contains an insert at the B/z 
splice site, is synthesized by motor neurons in the ventral horn of the spinal cord and then 
transported along the axons to the nerve terminal where it is secreted into the synaptic 
cleft. There it binds to laminin in the basal lamina (Denzer et al., 1997) and acts as a key 
regulator for the postsynaptic specialization. As soon as the growth cone of the developing 
motor neuron gets into contact with the muscle fiber, the distribution of AChR clusters 
begins to change dramatically. The synaptic density of the receptors increases to 
∼10000/µm2, the extrasynaptic density decreases to <10/µm2. 
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Fig. 4: The complexity of the NMJ 
The NMJ consists of the postsynaptic nerve terminal of the motor neuron (NT), the postsynaptic muscle membrane (M) and the 
surrounding Schwann cell (S) (Burden et al., 1979; Sanes and Lichtman, 1999). 
 
Neural agrin is active in aggregating AChRs, AChE and other proteins in the postsynapse. 
Agrin-deficient mice do not develop postsynaptic structures and die perinatally, because of 
respiratory failure (Gautam et al., 1996; for review see Ruegg and Bixby, 1998). The 
number and density of AChR clusters and the transcription of synapse-specific genes is 
notably reduced. Many proteins have been identified to bind directly to agrin, but only the 
muscle-specific receptor tyrosine kinase MuSK is required for agrin activity (Gautam et 
al., 1996). Mice lacking MuSK, which are similar to agrin-deficient mice fail, to induce 
postsynaptic specialization and die at birth (DeChiara et al., 1996). 
The axon of the motor neuron does not stop growing and does not differentiate into a 
presynaptic terminal. Agrin influences the growth and differentiation of motor neurons, 
which means that agrin is also involved in presynaptic differentiation. These observations 
show that agrin is indispensable for the formation of both pre- and postsynaptic structures. 
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Agrin in the Central Nervous System 
Most of our knowledge concerning the function of agrin derives from studies on the NMJ. 
Agrin is also highly expressed in the CNS. However its function in the CNS is mostly 
unknown. Owing to alternative mRNA splicing at the 5’end and alternate transcriptional 
start sites, two protein isoforms are characterized by their short or long amino-termini 
(Burgess et al., 2000; Neumann et al., 2001). The isoform with the long one (SS-NtA-
Agrin) can bind to γ 1-chains of laminins in the ECM (Denzer et al., 1997) and is present 
in muscle and other peripheral tissue. In contrast, the isoform characterized by the short 
amino-terminus (TM-Agrin), which lacks the laminin binding site, is a transmembrane 
protein typeII that is mainly expressed in the CNS. Owing to the high similarity of these 
two isoforms, they differ only in the amino-terminus. It is suggested that agrin might play a 
similar role in the CNS as at the NMJ (McMahan, 1990; Kirsch et al., 1996; Kroger and 
Schroder, 2002). Within the CNS, agrin is expressed in both non-neuronal and neuronal 
cells. Glial cells exclusively express the agrin isoform B/z0 that is inactive in AChR 
aggregation whereas neurons and also blood vessels express both B/z0 and B/z+ isoforms 
respectively (Kroger and Schroder, 2002). Agrin seems to exhibit much broader functions 
than has been assumed so far, synaptic and non-synaptic functions. However, the role of 
agrin in the brain is controversial. Mice lacking agrin show no abnormalities in brain 
development (Gautam et al., 1996). On the other hand, normal synaptic transmission is 
impaired when agrin expression is suppressed in cultured hippocampal neurons (Ferreira, 
1999). 
 
Non-Synaptic Functions of Agrin in the Central Nervous System 
Agrin is highly expressed in the ventricular and subventricular zone of the early 
developing brain suggesting that agrin is responsible for neuro- and also gliogenesis (for 
review see Smith and Hilgenberg, 2002). The expression level decreases in adult brains 
(Stone and Nikolics, 1995; Cohen et al., 1997a). Mice that lack agrin specifically in the 
brain survive, in contrast to homozygote agrin-/- mice, but they have smaller brains than 
wildtype-mice (Serpinskaya et al., 1999). There are no consistent differences between the 
histology of mutant and wildtype mice brains. 
Agrin may also play a central role in neurite outgrowth and axonogenesis as proteoglycans 
provide neurite outgrowth at an astrocyte boundary (Powell et al., 1997). The function as a 
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‘stop-signal’ (Campagna et al., 1995) is consistent with experiments where agrin is 
blocked and axonal and dendritic elongation persists (Mantych and Ferreira, 2001) and 
presynaptic differentiation is impaired and axonal arborization reduced (Bose et al., 2000). 
This multifunctional protein is also upregulated in the brain microvascular basal lamina 
during the development of the blood-brain barrier, around the time the vasculature 
becomes impermeable. Thus, agrin may function as an important player in the formation 
and maintenance of cerebral microvascular impermeability. (BBB; Barber and Lieth, 1997; 
Kroger and Schroder, 2002) It can also bind to β-amyloid and therefore accumulates in the 
amyloid plaques in the brain of Alzheimer’s patients (Cotman et al., 2000). 
 
Synaptic Functions of Agrin in the Central Nervous System 
The broad and predominantly neuronal distribution of agrin mRNAs in the CNS suggests 
that agrin may also play a role in the formation and maintenance of central synapses 
between neurons in the brain (O’Connor et al., 1994; Ma et al., 1994). It is also 
concentrated at the synapses of the retina (Ma et al., 1994; Mann and Kroger, 1996). 
Agrin, which is shown to play an essential role in the formation and maintenance of the 
NMJ, is also assumed to be important in the function of neuronal synapses in the CNS 
(Mann and Kroger, 1996; Koulen et al., 1999; Gingras and Ferns, 2001) because of higher 
concentration at synapses in the developing brain during the period of the synapse 
formation (Li et al., 1997). Much of the knowledge about agrin function during 
synaptogenesis in the CNS derives from suppression experiments, where it has been shown 
that inhibition of agrin expression on cultured hippocampal neurons decreases the number 
of GABA receptor clusters (Ferreira, 1999). The observation that agrin plays a role in 
differentiation of neural tissue provides evidence for an agrin receptor whose 
characterization is a crucial step for the understanding of agrin in the brain. 
 
Aim of Thesis 
Agrin is widely expressed in non-neuronal as well as neuronal cells. Its function is well 
studied and understood in skeletal muscle where it plays a key role during the formation, 
maintenance and regeneration of the neuromuscular junction (for review see Ruegg and 
Bixby, 1998; Sanes and Lichtman, 2001). But only little is known about agrin's role in 
other tissues, in particular in the CNS (for review see Kroger and Schroder, 2002). There is 
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accumulation of evidence that agrin is not only a component of the extracellular matrix but 
that it can also be expressed as a transmembrane protein (Burgess et al., 2000; Neumann et 
al., 2001). The aim of this thesis has been to analyse and elucidate the effect of TM-Agrin 
expression on non-neuronal and neuronal cells and to get a deeper understanding of the 
role of agrin in the brain (Chapter II and III). 
Agrin is the key neural factor that controls muscle postsynaptic differentiation, including 
the induction of synapse-specific gene transcription. In Duchenne muscular dystrophy, the 
x-linked gene encoding dystrophin has mutated. It has been shown that utrophin can 
functionally compensate dystrophin. Agrin is a potential factor to upregulate utrophin 
expression (Gramolini et al., 1998). Thus the second aim of the thesis has been to create a 
mouse model where expression of agrin can be temporally controlled to test whether such 
upregulation and the subsequent formation of postsynaptic-like structures could be a means 
to ameliorate the phenotype of mdx mice, a mouse model for Duchenne muscular 
dystrophy (Chapter IV). 
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Summary 
Agrin is a basal lamina-associated heparansulfate proteoglycan that is a key molecule in 
the formation of the vertebrate neuromuscular junction. The carboxy-terminal part of agrin 
is involved in its synaptogenic activity. The amino-terminal end of chick agrin consists of a 
signal sequence, required for the targeting of the protein to the secretory pathway, and the 
amino-terminal agrin (NtA) domain that binds to basal lamina-associated laminins. The 
cDNA encoding rat agrin lacks this NtA domain and instead codes for a shorter amino-
terminal end. While the NtA domain is conserved in several species, including human, 
sequences homologous to the amino-terminus of rat agrin have not been described. In this 
work, we have characterized these amino-terminal sequences in mouse and chick. We 
show that they all serve as a nonleaded signal anchor (SA) that immobilizes the protein in 
an Ncyto/Cexo orientation in the plasma membrane. Like the secreted form, this 
transmembrane form of agrin is highly glycosylated indicative of a heparansulfate 
proteoglycan. The structure of the 5’end of the mouse agrin gene suggests that a distinct 
promoter drives expression of the transmembrane form. Agrin transcripts encoding this 
form are enriched in the embryonic brain, particularly in neurons. To our knowledge, this 
is the first example of a molecule that is synthesized both as a basal lamina and a plasma 
membrane protein. 
 
Introduction 
Several lines of evidence have indicated that the heparansulfate proteoglycan agrin is a key 
regulator of synaptogenesis at the developing and regenerating neuromuscular junction 
(NMJ; for review see Ruegg and Bixby, 1998). For example, agrin induces the formation 
of postsynaptic specializations including aggregates of acetylcholine receptors (AChRs) 
and other molecules on cultured myotubes in vitro (Nitkin et al., 1987; Reist et al., 1992). 
Targeted inactivation of agrin in mice results in grossly malformed NMJs, which display 
only very few pre- and postsynaptic specializations (Gautam et al., 1996). Accordingly, 
these mice die at birth due to nonfunctional respiratory musculature (Gautam et al., 1996). 
In addition, ectopic expression of agrin in extrajunctional regions of skeletal muscle fibers 
triggers the formation of postsynaptic specializations that includes the induction of 
endplate-specific gene transcription of the ε-subunit of the AChR, characteristic of the 
mature AChR (Jones et al., 1997; Meier et al., 1998b; Rimer et al., 1997). This activation 
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of synaptic gene transcription is likely to involve the Ets-related transcription factor GABP 
(Schaeffer et al., 1998; Briguet and Ruegg, 2000). In summary, agrin is necessary and 
sufficient for the induction of postsynaptic specializations at the NMJ. 
Agrin cDNAs have been isolated from rat, chick, marine ray, and human (Rupp et al., 
1991; Tsim et al., 1992; Smith et al., 1992; Groffen et al., 1998). In all species the majority 
of the sequence is highly homologous and the domain structure of the deduced proteins is 
conserved. In rat and chick, the only two species in which full-length cDNAs have been 
described, agrin has a predicted molecular weight of approximately 220kDa. In vivo, agrin 
is highly glycosylated and migrates on SDS–PAGE under reducing conditions with a 
molecular weight of approximately 500kDa. Since the molecular weight can be reduced to 
that of the core protein by digestion with heparitinases, agrin belongs to the family of 
heparansulfate proteoglycans (Tsen et al., 1995; Denzer et al., 1995). At least three 
glycosaminoglycan side chains have been observed using electron microscopy after rotary 
shadowing (Denzer et al., 1998). 
The agrin gene is subject to alternative mRNA splicing at several sites. Alternative exon 
usage at positions A and B (called y and z in rodents) at the 3’end of the cDNA has a 
strong influence on the biological activity of agrin. Only those isoforms are active at the 
NMJ in vitro and in vivo which have a peptide insert at both sites (Ruegg et al., 1992; 
Ferns et al., 1993; Gesemann et al., 1995; Cohen et al., 1997a; Burgess et al., 1999). In 
contrast, agrin isoforms without a peptide insertion at these sites have no synaptogenic 
activity at the NMJ, although these isoforms might be involved in later steps of endplate 
maturation (Meier et al., 1997; Cohen et al., 1997a; Burgess et al., 1999). Several other 
splicing sites have been identified, some of which appear to be species-specific and the 
biological role of these sites is entirely unclear (Rupp et al., 1991; Tsen et al., 1995b; 
Denzer et al., 1995). Agrin transcripts are widely expressed throughout the peripheral and 
the central nervous system (O’Connor et al., 1994; Stone and Nikolics, 1995; Kroger et al., 
1996; Cohen et al., 1997b). Importantly, alternatively spliced transcripts encoding AChR 
aggregating and inactive versions of agrin are expressed in distinct cell types. For example 
neurons, including motor neurons, express agrin isoforms that are active in AChR 
aggregation while non neuronal cells, including muscle, kidney, lung, or glial cells, express 
isoforms that are inactive in this process (for review see Ruegg and Bixby, 1998). 
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Expression of agrin in the brain is particularly high during development and continues to 
be high in non-neuronal tissue like kidney and lung. 
While the 3’end of the agrin gene is highly conserved between species and its function in 
postsynaptic differentiation is well established, the 5’end is less well characterized. In 
particular, a discrepancy exists between species with regard to the published 5’end 
sequences. The most 5’end of chick agrin contains a signal sequence and the NtA domain. 
The NtA domain confers binding of agrin to the γ1 chain of the laminins and is therefore 
important for immobilizing agrin in basal laminae (Denzer et al., 1997, 1998; Kammerer et 
al., 1999). This 5’end of agrin has been described in human, bovine, and mouse and its 
sequence is highly conserved across species (Denzer et al., 1995; Groffen et al., 1998). A 
different 5’end of agrin has been reported for rat agrin (Rupp et al., 1991). There, the full-
length cDNA codes for a shorter 5’end that is also supposed to encode a secreted form of 
agrin (Rupp et al., 1991; Campanelli et al., 1991). Because this form lacks the NtA 
domain, it is not clear how it binds to basal lamina. Moreover, this shorter version of agrin 
has not been identified in any other species. We therefore decided to analyze the 5’end of 
the agrin gene in more detail. In this study, we show that 5’ends homologous to the rat 
sequence also exist in mouse and chicken. We show that this form is generated by usage of 
an alternative first exon. We further show that this alternative amino-terminus does not 
serve as signal peptide but as a non-cleaved signal anchor, thus generating a type II 
transmembrane protein (Nilsson et al., 1994). This transmembrane form of agrin is most 
likely regulated by an alternative promoter, is conserved between several species, and is 
primarily expressed in the central nervous system. Thus, the heparansulfate proteoglycan 
agrin also exists as a transmembrane molecule. 
 
Results 
The Two Different Amino-Termini are Conserved across Species 
To investigate whether the amino-terminal end for rat agrin (Fig. 5A; Rupp et al., 1991) is 
unique for this species, we performed reverse transcription followed by polymerase chain 
reaction (RT-PCR) on RNA isolated from different mouse tissues. To increase the 
specificity of the reaction, reverse transcription was initiated using a primer specific for 
mouse agrin. Subsequent PCR was performed using a nested agrin-specific antisense 
primer and a degenerate sense primer that was designed based on the published 5’sequence 
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of rat agrin. Using this strategy, PCR products were detected from RNA isolated from 
embryonic brain and spinal cord, kidney, and from the C2C12 muscle cell line. These PCR 
products were cloned and sequenced (Fig. 5B) confirming that mice also express agrin 
isoforms encoding the alternative amino-terminus described in rat. To further test the 
degree of conservation of this amino-terminus, we next performed primer extension 
analysis on RNA isolated from spinal cord and brain of 6-day-old chick embryos. Indeed, 
in both tissues, specific PCR products could be isolated that were derived from agrin 
mRNA encoding the alternative amino-terminus (Fig. 5B). The longest PCR product was 
500bps long and contained 238bps of 5’untranslated region. As shown in Fig. 5B, the 
nucleotide sequences of mouse and rat agrin are highly homologous. In contrast, the 
sequence for chick agrin shows a low conservation in the 5’untranslated region and at the 
beginning of the protein-coding region. Indicative of initiation of translation at the ATG 
highlighted in Fig. 5B, the first in-frame stop codons in mouse and chicken are found 12 
and 57 nucleotides upstream, respectively. In addition, the ATG is preceded by a Kozak 
consensus sequence in all species. 
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B 
       1                                                                                                         100  
  rat  ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~T GCTTATCTCC TACCATGAAC CTGGAGGGCT GGGGAGAGGA  
mouse  ~~~~~~~~~~ ~~~~~~~~~~ ~~~~~~~~~~ ~~AGTGGATC CCCCGGGCTG CAGGAATTCT TCTTATCTCC TGCCATGAGC CTGGAGGGCT GGGGAGAGGG  
chick  GGGCTGGGAG GGTCTCTCCG GAGCACACTC AGACCCATGA TGGCAGATGT GGGGATGAAC TCTTGGTCCT GAAGGTGCCA CCAACCTGCC CTGCCCTCCT  
 
       101                                                                                                       151  
  rat  CCTGGTGCTC CCCTAGCCAT AACTGGCTAA ACTTTGAGAT CACAGCTG.C ATCTGCTGCT CCAGAGCACC CAGCATGGGG GGAGTAGCTC CGAAGAGGCC  
mouse  CCCGGTGCTC CCCTAGCCAC AACTGGCTAA ACTTTGCTAT CACAGCTGCC ATCTGCTGCT CCAGAGCACC CAGCATGGGG GGAGTAGCTC CGAAGAGGCC  
chick  GTTCCCTAGA GGATGGGAAC CTCTGGGAAA ACTGGGGTCT TGCTGCTGCC GAAAAGAGGG GAACGGAGGG CATCTGTGTG AGCCTCGTGG CCGCTCTGCC  
 
       201                                                                                                       300  
  rat  TAAGGGCACT CCATAAGAAC TCCCACACAC ACCCAGGAAT TGGGCTCGAG CTGTATGTAT CATGCCTCCT CTGCCACTGG AACACAGACC CAGGCAGGAG  
mouse  TAAAGGCCCT CCATAAGAAC GCCC.CACAC CCCCAGGGAC TGGGCTAGAG C....CGTAT CATGCCTCCT CTGCCACTGG AACACAGACC CAGGCAGCAG  
chick  TTGGATGGGT CACCAGCAGG TTGAACTTTG AGCACAGCAT GACGGCTTGC CAGTAC..CC CATGGCACCG GGGGCCTTGG AGCGGGACCG GCTGTACCAG  
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       301                                                                                                       400  
  rat  CCTGGTGCCT CCATGCTGGT TCGATACTTC ATGATCCCCT GCAACATCTG CTTGATCCTG TTGGCCACTT CCACATTGGG CTTTGCGGTT CTGCTTTTCC  
mouse  CCTGGTGCCT CCGTGCTGGT TCGGTACTTC ATGATCCCCT GCAACATCTG CTTGATCCTC TTGGCTACTT CTACGTTGGG CTTTGCGGTG CTGCTTTTCC  
chick  CACAAGGTCT CCTTGGTGGT GCGCTACTTC ATGATCCCGT GCAACATTTG CCTCATCCTC CTGGCCACCT CCACGCTGGG ATTTGCTGTG CTGCTCTTCC  
 
       401 
  rat  TCAGCAACTA 
mouse  TCAGCAACTG 
chick  TCAATAACTA 
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Fig. 5: Identification of alternative 5’ends homologous to rat agrin in mouse and chick 
(A) Schematic representation of the protein structures as deduced from full-length cDNAs in chick and rat. The amino-terminus of chick 
agrin encodes a signal sequence (SS) followed by the NtA domain (Denzer et al., 1995; Denzer et al., 1997). Rat agrin encodes a shorter 
amino-terminal end (Rupp et al., 1991) not described in any other species. The two proteins become highly homologous in a linker 
region (gray) that precedes the first follistatin-like domain (FS). For details on structural motifs of agrin see Ruegg and Bixby (1998). 
Sites of alternative mRNA splicing are indicated by ٨. (B) Alignment of nucleotide sequences homologous to rat agrin. Putative sites of 
initiation of translation are indicated by boxes. (C) Genomic organization of the 5’end of mouse agrin. Name and size of DNA fragments 
used for the mapping are shown (lines). The genomic sequence published by Rupp et al. (1992) is indicated by a broken line. Regions 
that were fully sequenced are indicated by thick lines. The deduced structure of the mouse agrin gene is given at the bottom. Note that 
the signal sequence and the NtA domain are encoded by two exons. A large intron of ∼8.6kbs precedes the exon encoding the sequence 
homologous to rat agrin. The two amino-termini converge at the linker region (gray). RNA splicing for the two different forms is 
indicated (broken line and dotted line, respectively). 
 
The mouse agrin gene described so far ends at the exon encoding the first follistatin-like 
domain (Fig. 5C; Rupp et al., 1992). To further compare the two amino-termini of agrin 
and to determine whether they derive from alternative mRNA splicing, we isolated the 
gene encoding the 5’end of the mouse agrin gene. To this end, bacterial artificial 
chromosome (BAC) DNA libraries were screened using a probe corresponding to the last 
128bps encoding the secreted version of agrin (NtA domain) and one probe encoding the 
first 132bps of the alternative amino-terminus. Using this approach, we were able to 
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identify a single BAC clone that was positive for both probes. After isolation of DNA, the 
BAC inserts were further digested with appropriate restriction enzymes and the DNA 
fragments containing the different regions of the agrin gene were subcloned and their 
sequence was determined (see Experimental Methods). Digestion of DNA by restriction 
enzymes and partial sequencing of 5 subclones allowed compiling the entire 5’end of the 
mouse agrin gene (Fig. 5C). The most 5’localized clone, HB4, contains the 5’untranslated 
region preceding the amino-terminal part of agrin encoding the NtA domain. The 
overlapping clone, EcoN, comprises the first exon encoding the initiation methionine of the 
signal sequence and the amino-terminal part of the NtA domain. It overlaps with the 
largest, approximately 11-kb-long fragment, XhoNS, which encodes the second half of the 
NtA-domain and extends up to the alternative amino-terminus. Finally, the most 
3’localized clone, EcoS, contains the entire 5’end of the alternative amino-terminus. At its 
3’end, more than 1kbs are identical to the published sequence of the mouse agrin gene 
(Rupp et al., 1992). Because we sequenced some of the fragments only partially, the sizes 
of the introns between exons encoding the NtA domain and the alternative amino-terminus, 
and between the linker region and the first follistatin like domain, are not known exactly. 
Based on restriction digests, we estimate them being 8.6 and 5.8kbs long, respectively (Fig. 
5C). In summary, isolation of the mouse gene encoding agrin revealed that the signal 
sequence and the NtA-domain of agrin are encoded by two separate exons, while the 
alternative amino-terminus is encoded by a single exon. Moreover, the large distance 
between the exon coding for the second part of the NtA-domain and that coding for the 
alternative amino-terminus strongly suggests that expression of the alternative form of 
agrin is regulated by a separate promoter. 
 
The Alternative Amino-Terminus Serves as Signal Anchor 
Searching databases for protein sequences homologous to the alternative amino-terminus 
of rat agrin yielded one expressed sequence tag (EST), isolated from human B-cells 
derived from chronic lymphotic leukemia (Lennon et al., 1996). Figure 6A shows the 
alignment of the deduced protein sequence from all four species. While the most amino-
terminal ends are less conserved across species, a very high degree of conservation is 
observed further downstream. Interestingly, this highly conserved stretch is hydrophobic, 
indicative of a transmembrane segment. 
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A 
                 1                                                     57 
      rat  ~~~~~~~MPP LPLEHRPRQE PGASMLVRYF MIPCNICLIL LATSTLGFAV LLFLSNY 
    mouse  ~~~~~~~MPP LPLEHRPRQQ PGASVLVRYF MIPCNICLIL LATSTLGFAV LLFLSNY 
human_est  ~~~~~~~MPX LAVARDTRQP AGASLLVRGF MVPCNACLIL LATATLGFAV LLFLNNY 
    chick  MTACQYPMAP GALERDRLYQ HKVSLVVRYF MIPCNICLIL LATSTLGFAV LLFLNNY 
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Fig. 6: The amino-terminus homologous to rat agrin is predicted to serve as a noncleaved signal anchor 
(A) Alignment of deduced protein sequences from rat, mouse, a human expressed-sequence-tag (human-est), and chick. Conservation is 
low at the very amino-terminal end but becomes very high towards the carboxy-terminus. Identical amino acids are indicated (yellow). 
Note that the chick sequence is predicted to be 7 amino acids longer than the other sequences as the initiation site indicated in Fig. 5A is 
the first in-frame methionine. (B) The software SignalP-HMM (Nielsen and Krogh, 1998) predicts a cleaved signal peptide for the 
amino-terminus described in full-length chick agrin (Denzer et al., 1995). This is indicated by the high score for the n-region (blue line) 
and the h-region (red line) at the very most amino-terminal end of the protein. Importantly, the program predicts a high probability for 
signal peptidase cleavage after the hydrophobic h-region (vertical bars). (C) SignalP-HMM predicts a noncleaved signal anchor for the 
alternative amino-terminal sequence from chick (dotted line) and mouse (solid line). The high scores for the h-region are shifted to the 
carboxy-terminal end and no signal peptidase cleavage site is predicted. 
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To characterize the sequences more fully, we analyzed all of them with the signal peptide 
prediction program SignalP V2.0 (Nielsen, 1997). To distinguish between cleaved signal 
peptides and non-cleaved signal anchors (SA), we used a modified version of the program 
making use of hidden Markov models (SignalP-HMM; Nielsen and Krogh, 1998). 
The program predicted a cleaved signal peptide with a probability of 99.9% for the 
secreted form of chick agrin. As shown in Fig. 6B, such a targeting sequence is 
characterized by a short n-region (blue) followed by a short, hydrophobic h-region (red 
line). Most importantly, they show a high probability for cleavage by the signal peptidase 
after the hydrophobic region (vertical bars in Fig. 6B). Using the protein sequence of the 
alternative amino-termini of chick and mouse agrin, the SignalP-HMM program predicted 
non-cleaved SAs. These are characterized by a positively charged n-region at the amino-
terminal end (blue line) followed by a hydrophobic region (h-region; red line) that is 
usually longer than classical signal peptides (Fig. 6C; Nilsson et al., 1994). The predicted 
probabilities for non-cleaved SAs were above 90% in all species (mouse: 99.4%; 
human_est: 91.7%; chick: 98.5%). 
The presence of a single non-cleaved SA at the amino-terminus results in a protein with a 
single transmembrane segment where the amino-terminus lies inside and the carboxy-
terminal outside of the cell (Ncyto/Cexo orientation; type II transmembrane protein). To 
validate this prediction, we compared protein targeting and the orientation of different 
agrin constructs after transfection of COS-7 cells. To allow detection of the recombinant 
protein, the constructs were fused to human placental alkaline phosphatase (AP; Berger et 
al., 1988) at their carboxy-terminal end (Fig. 7A). To determine the orientation of the 
recombinant protein, one construct was also tagged with a six fold repeated myc-epitope 
(Evan et al., 1985). A similar construct derived from the secreted version of mouse agrin 
(SS-NtA-AP) served as the positive control. In a first set of experiments, transfected COS 
cells were stained alive at 4°C with an antibody directed against the AP fusion protein. As 
shown in Fig. 7B (upper panel), strong staining was observed when COS cells were 
transfected with constructs encoding the alternative amino-terminus (TM-FS-AP) and no 
specific staining could be seen with the control construct (SS-NtA-FS-AP). The latter 
construct could be visualized only if cells were permeabilized before the staining (Fig. 7B; 
lower left). Intracellular staining of TM-FS-AP was dominated by the staining of the cell 
membranes (Fig. 7B, lower right). 
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Fig. 7: Constructs encoding the new amino-terminus are inserted into the cell membrane of transfected COS cells 
(A) Constructs used in this study encode the SS-NtA amino-terminus of mouse agrin, fused to placental alkaline phosphatase (AP) as a 
reporter (SS-NtA-FS-AP, top), the new amino-terminus predicted to be a transmembrane protein (TM-FS-AP, middle) and TM-FS-AP 
that was additionally tagged with six copies of a myc epitope (myc-TM-FS-AP, bottom). (B) COS cells transfected with SS-NtA-FS-AP 
(left column) or TM-FS-AP (right column) were stained with an anti-AP antibody. When the COS cells were stained alive (surface, top 
row), only COS cells expressing TM-FS-AP were positive. COS cells transfected with SS-NtA-AP showed immunoreactivity in the 
endoplasmatic reticulum and the Golgi apparatus after permeabilization (bottom row). (C) Quantification of AP activity in the 
conditioned medium (sup) and the cell lysate (cell). While the majority of the SS-NtA-FS-AP construct accumulates in the conditioned 
medium, most of the TM-FS-AP construct remains associated with COS cells. The values shown are the mean ±SEM from six 
independent experiments. (D) The amino-terminal myc tag cannot be stained in living COS cells (left), showing that the epitope is not 
accessible from the outside. Only after permeabilization of the cells with detergent, the transfected cells are brightly stained (right). Bar, 
20µm. 
 
As the presence of the AP fusion construct allowed quantification of the protein 
concentration in the different compartments, we measured the concentration of AP in the 
medium and in the COS cells 2 days after transfection. Again, the secreted version of agrin 
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served as the internal control. With this construct, more than 90% of the AP activity was 
detected in the medium (Fig. 7C, left column; sup) and only little AP activity was 
associated with the cells (Fig. 7C, left column; cell). In contrast, only approximately 15% 
of the total AP activity accumulated in the medium and 85% was found in the cell fraction, 
when COS cells were transfected with the construct encoding the alternative amino-
terminus (Fig. 7C; right column). These results therefore support the conclusion that the 
alternative amino-terminus of agrin serves as a non-cleaved signal anchor. 
To test the orientation of the protein in the plasma membrane, we next transfected a 
construct into COS cells that carried an additional myc-tag at its amino-terminal end (see 
Fig. 7A). In non-permeabilized cells, the anti-myc monoclonal antibody 9E10 (Evan et al., 
1985) did not stain any of the transfected cells (Fig. 7D, left panel). If COS cells were 
permeabilized before 9E10 was added, a strong cell membrane staining was observed (Fig. 
7D, right panel). This staining pattern was indistinguishable from the intracellular staining 
with the anti-AP antibody (data not shown, but see Fig. 7B for comparison). The same 
Ncyto/Cexo orientation was also seen upon transfection of COS cells with the full-length 
cDNA encoding the chick version of the transmembrane form of agrin. There, antibodies 
raised against the N-terminal end did not stain transfected COS cells without 
permeabilization, while antibodies rose against the C-terminal part of agrin did stain (data 
not shown). Thus, the amino-terminus of this construct is localized to the cytoplasm of the 
transfected COS cells, which confirms the prediction that this alternative amino-terminus 
of agrin is sufficient to confer a type II transmembrane orientation to the protein. We 
therefore name this form of agrin transmembrane-Agrin (TM-Agrin). For clarity, we will 
call the secreted form of agrin in the following sections “SS-NtA-Agrin”, which is based 
on its domain structure at the amino-terminus. 
 
The Transmembrane Form of Agrin is Highly Glycosylated and Induces 
AChR Aggregation 
The secreted form of agrin (SS-NtA-Agrin) expressed in COS cells carries heparansulfate 
glycosaminoglycan side chains indicative of its being a heparansulfate proteoglycan 
(HSPG; Tsen et al., 1995b; Denzer et al., 1995). Moreover, agrin isolated from several 
tissues, including brain, has an appearance on SDS–PAGE reminiscent of a HSPG (Tsen et 
al., 1995a; Denzer et al., 1995; Gesemann et al., 1998). To evaluate whether the 
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transmembrane form of agrin (TM-Agrin) undergoes the same posttranslational 
modifications as the secreted version, we assembled a cDNA encoding full-length chick 
TM-Agrin and expressed the protein in COS cells. 
B
 
 
Fig. 8: The transmembrane form of agrin is highly glycosylated and induces the aggregation of AChR on cultured myotubes 
(A) Agrin-like protein synthesized by COS cells transfected with full-length cDNAs encoding the transmembrane form of chick agrin 
(TM-Agrin), the secreted form of chick agrin (SS-NtA-Agrin) or with vector alone (Mock) were labeled with [35S]methionine for 48h. 
The conditioned medium (sup) was collected and the cells were chased for 3h in the presence of non-labeled methionine. The COS cells 
were then lysed with detergents (cell). Agrin-like protein was immunoprecipitated with anti-agrin antibodies, separated on SDS–PAGE, 
and visualized by fluorography. Molecular weights of standard proteins are given in kDa. Arrow indicates agrin-like protein. The 
immunoreactive band below the smear (sup; SS-NtA-Agrin) was not observed consistently and may reflect incomplete glycosylation of 
the protein due to its overexpression. (B) Myotubes and TM-Agrin-transfected HEK293 cells were co-cultured for 24h and subsequently 
stained with anti-agrin antibodies (green) and with rhodamine-conjugated α-bungarotoxin (red) to visualize AChRs. Aggregation of 
AChRs at the site of myotube/HEK cell contact was observed, indicating that TM-Agrin is active in AChR clustering and that focal 
application of TM-Agrin induces the local aggregation of the AChR. Bar, 10µm. 
 
Transfected COS cells were labeled with 35[S]methionine for 2 days. After harvesting the 
medium, COS cells were chased with non radioactive methionine for 3h. Agrin-like protein 
was immunoprecipitated from conditioned medium and the cell lysate, separated on SDS–
PAGE, and processed for fluorography. As shown in Fig. 8A, the secreted form of agrin 
accumulated in the conditioned medium (SS-NtA-Agrin; sup) and migrated on SDS–
PAGE with an apparent Mr of more than 400 kDa. In addition, only little agrin-like protein 
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was found in the cell lysate (SS-NtA-Agrin; cell). In strong contrast, in COS cells 
transfected with TM-Agrin, only little protein was found in the supernatant (TM-Agrin; 
sup) and the majority of the protein was associated with the cell lysate (TM-Agrin; cell). 
Importantly, the transmembrane form of agrin displayed a similar Mr on SDS–PAGE like 
the secreted form, indicating that it is also a HSPG. 
The transmembrane form of agrin was also capable of inducing AChR clustering when 
transfected human embryonic kidney HEK293 cells were co-cultured with chick muscle 
cells (Fig. 8B). AChR were predominantly clustered at the site of direct contact between 
HEK 293cell and the myotubes. This is independent evidence that TM-Agrin is inserted in 
the membrane of HEK293 cells in a Ncyto/Cexo orientation because the C-terminal part of 
agrin is required to induce AChR aggregation on cultured muscle cells (Nitkin et al., 1987; 
Tsim et al., 1992; Ferns et al., 1993; Gesemann et al., 1995). 
 
Transcripts Encoding the Transmembrane Form of Agrin are Enriched in 
the CNS 
The structure of the agrin gene indicates that the secreted and the transmembrane form use 
distinct promoters (Fig. 5C). This suggested to us that the two forms might be differentially 
expressed. To address this question, we used real-time quantitative PCR (Head et al., 
1996) with primers and probes specific for the first FS-like domain (pan-Agrin), the 
transmembrane form (TM-Agrin) and the secreted form (SS-NtA-Agrin). To normalize the 
amount of mRNA for each tissue, primers and probes specific for glyceraldehyde-3-
phosphate-dehydrogenase (GAPDH) were used. Because the total amount of agrin mRNA 
expressed in each tissue must correspond to the sum of transcripts encoding the 
transmembrane and the secreted form of agrin, we first determined standard curves for the 
PCR reaction for probes specific for each form. To this end, we generated a construct that 
contained all three regions of agrin (SS-NtA, TM, and FS). Using different concentrations 
of this construct, we were able to determine the amplification efficiency for each set of 
agrin primers (see Experimental Methods). The amount of mRNA determined for the 
different primer sets was then adjusted based on the amplification efficiency. 
When we measured the relative amount of agrin mRNA encoding all agrin isoforms (pan-
agrin), we found that a similar amount of agrin mRNA was expressed in each tissue (data 
not shown). This value was set to 100% and the relative contribution of TM-Agrin and SS-
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NtA-Agrin was calculated using the amplification efficiency determined with the standard 
curves (see above). 
The mRNA of E11 skeletal (SM) heart muscle (HM), spinal cord (SC) and brain (BR) was 
extracted. As shown in Fig. 9A, the contribution of individual agrin forms varied 
considerably between the different tissues. No or very little mRNA coding for TM-Agrin 
was detected in E11 skeletal and heart muscle and most, if not all agrin transcripts encoded 
SS-NtA-Agrin. In contrast, approximately 15% of the agrin mRNA expressed in spinal 
cord (SC) corresponded to TM-Agrin and the highest percentage of mRNA encoding TM-
Agrin was detected in brain (BR). In brain, this form of agrin contributed almost 50% of 
the entire agrin mRNA. These experiments, thus, indicate that the transmembrane form of 
agrin is not expressed in peripheral, non neuronal cells and that its contribution is highest 
in the brain, suggesting that TM-Agrin may be most strongly expressed in CNS neurons or 
glial cells. 
To validate this further, we performed RT-PCR on mRNA preparations of the retina from 
several embryonic stages. We chose the chick retina, since agrin in the retina has been 
extensively characterized and since the retina does not contain blood vessels, which have 
agrin immunoreactivity associated (Magill-Solc and McMahan, 1988) and which could 
therefore interfere with the analysis of neural agrin. As shown in Fig. 9B, transcripts 
coding for SS-NtA-Agrin (upper panel) and TM-Agrin (lower panel) were detected in E8 
to E16 retina. The presence of transcripts coding for TM-Agrin at stages before retinal 
synapses develop, which in chick occurs around E12 (Hering and Kroger, 1996), indicates 
that TM-Agrin might have functions in the retina during very early stages of development. 
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Fig. 9: Transcripts encoding the transmembrane form of agrin are enriched in the brain 
(A) Quantitative real-time PCR of E11 chick skeletal muscle (SM), heart muscle (HM), spinal cord (SC), and brain (BR) using primers 
and probes specific for the first follistatin-like domain (pan-Agrin), the secreted form (SS-NtA-Agrin), and the Transmembrane from 
(TM-Agrin). TM-Agrin was not detected in skeletal muscle and heart but was clearly detected in spinal cord and brain with the highest 
levels in brain. Values given represent the mean ±SEM of three independent experiments. (B) mRNA from chick retinae of different 
developmental stages (E8, E12, E16) was analyzed for expression of SS-NtA-Agrin (upper panels) and of TM-Agrin (lower panels). At 
all stages, both forms of agrin could be identified, demonstrating the expression of TM-Agrin before, during and after synaptogenesis in 
the retina. (C) E6 retinal ganglion cells, which were purified by immunopanning (lane RGC), and retinal cell dissociate (lane D) were 
analyzed for the expression of SS-NtA-Agrin and TM-Agrin. While the retinal cell dissociate contained both forms of agrin, RGCs 
express only TM-Agrin. 
 
To analyze in more detail which cells of the retina express the transmembrane form of 
agrin, we purified retinal ganglion cells (RGC) from E6 chick retina by immunopanning 
(Barres et al., 1988). This procedure resulted in a cellular fraction in which RGCs 
represented more than 97% of all cells (data not shown). In RGCs (lane RGC; Fig. 9C), we 
could not detect a PCR product specific for SS-NtA-Agrin while a strong band was seen in 
the retinal cell dissociate (lane D; Fig. 9C). In contrast, both cell fractions gave rise to PCR 
products specific for TM-Agrin (lower panel; Fig. 9C). The controls of the first and second 
(nested) PCR, as detailed under Experimental Methods, were negative (lanes C1and C2 in 
Figs. 9B and 9C), demonstrating the specificity and the absence of a contamination in both 
PCR reactions. Sequencing of obtained PCR products showed that they were indeed 
derived from SS-NtA-Agrin and TM-Agrin, respectively (data not shown). We conclude 
that E6 retinal ganglion cells synthesize transcripts encoding the transmembrane form of 
agrin but not the secreted form. 
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To compare the localization of the transmembrane form of agrin with the secreted form of 
agrin, we analyzed their distribution in the E6 chick retina, using anti-peptide antisera 
generated against the specific forms of agrin. Cryostat sections stained with a panspecific 
antiserum against agrin are shown in Fig. 10A. As has been described previously (Kroger 
and Mann, 1996; Kroger et al., 1997), agrin-like immunoreactivity is associated with the 
inner limiting membrane (ILM; arrows in Figs. 10A–10C), a basal lamina that separates 
the neural retina from the vitreous humor (Halfter et al., 1987; Kroger and Mann, 1996). 
This antiserum also stained the axons of retinal ganglion cells (asterisks in Figs. 10A–
10C), which grow fasciculated centripetally within the optic fiber layer (OFL in Figs. 
10A–10C) of the retina to the optic nerve head. In contrast, antibodies specific for the 
cytoplasmic part of the transmembrane form of agrin exclusively stained the axon fascicles 
of retinal ganglion cells, but did not label the ILM (Fig.10B). Conversely, anti-peptide 
antisera against the NtA domain of agrin exclusively labeled the basal lamina but not the 
ganglion cell axons in the OFL (Fig. 10C). These results demonstrate a differential 
distribution of SS-NtA-Agrin and TM-Agrin in the E6 retina, with the transmembrane 
form of agrin being cell-associated and the secreted form being associated with the 
extracellular matrix. 
 
Discussion 
Our study provides strong evidence that agrin is not only a component of the extracellular 
matrix but that it is also expressed as a cell surface protein. We show that this form is a 
type II transmembrane protein where the amino-terminus is localized in the cytoplasm and 
the carboxy-terminus is exposed to the outside of the cell. This transmembrane form is 
generated by the usage of an alternative amino-terminal end whose sequence encoding the 
segment important for the incorporation into the plasma membrane is identical in chick, 
mouse, and rat.  
We also provide evidence that the transmembrane form of agrin is a HSPG and that it is 
preferentially expressed in the CNS. In developing chick retina, we show that the 
transmembrane form of agrin is expressed by retinal ganglion neurons while the basal 
lamina-bound form is specifically associated with inner limiting membrane. 
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The Role of the Transmembrane Form at the NMJ 
The usage of the alternative amino-terminal signal anchor eliminates agrin binding site to 
the laminins. This raises the question whether the transmembrane form of agrin plays a 
role in the formation of the NMJ. The current evidence indicates that this is not the case. 
For example, RT-PCR has shown that embryonic day 6 chick motor neurons express high 
amounts of the secreted form of agrin (Denzer et al., 1995). Importantly, agrin-mutant 
mice in which the secreted form has been selectively inactivated show the same phenotype 
as mice that do not express any agrin at all (R. W. Burgess. Skarnes, and J. R. Sanes, 
Abstract to Soc. Neurosci. Meeting, 1999). 
 
 
Fig. 10: Differential expression of the secreted and the transmembrane form of agrin in the retina 
Cryostat sections from E6 chick retinae were stained with a pan-specific rabbit anti-agrin antiserum (A), with a sheep anti-TM-Agrin 
antiserum (B) or an antiserum reacting specifically with the NtA domain (C). The pan-specific antiserum stained the inner limiting 
membrane (ILM; arrows in A and C) and the ganglion cell axons in the optic fiber layer (OFL; asterisks in A and B). In contrast, the 
antiserum against the transmembrane form of agrin detected immunoreactivity only in the OFL, while the ILM was not stained. 
Conversely, the antiserum against the NtA domain specifically labeled the ILM, but showed no immunoreactivity in the OFL. Bar, 
50µm. 
 
Moreover, transgenic expression of a cDNA construct encoding the secreted form of chick 
neural agrin in motor neurons is sufficient to rescue the NMJ phenotype of agrin-deficient 
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mice (I. Ksiazek and MA. Ruegg., unpublished observation). These observations, together 
with our finding that the expression of the transmembrane form is highest in the brain 
suggest that this agrin form does not play a critical role in the formation of the NMJ. 
Because embryonic muscle is also devoid of the transmembrane form (Fig. 9B), the NMJ 
is likely to contain no agrin protein encoding this isoform. 
 
Potential Role of the Transmembrane Form of Agrin in the CNS 
Several lines of evidence suggest that agrin plays a role during brain development. In 
particular, there is circumstantial evidence that agrin may play a role during 
synaptogenesis in the CNS. For example, agrin transcripts are highly expressed in the 
developing brain and mRNA expressed by neurons codes for agrin splice variants that are 
active in aggregating AChRs in muscle cells (for review see Ruegg and Bixby, 1998). In 
addition, the protein is concentrated in the synaptic cleft of inter neural synapses in the 
retina (Koulen et al., 1999). Agrin also induces cellular responses in CNS neurons, 
including phosphorylation of CREB (Ji et al., 1998) and expression of the immediate early 
gene c-fos (Hilgenberg et al., 1999). Moreover, antisense experiments on cultured 
hippocampal neurons have recently shown impairment of dendritic growth and of the 
numbers of synaptic contacts (Ferreira, 1999). Our results presented here add further 
evidence that agrin may play a role in the brain. As a transmembrane molecule, agrin could 
exert its function by being presented on the cell surface of neurons. Thus, eliciting an 
agrin-mediated response does not require its immobilization in a basal lamina, but instead 
cell–cell contact appears to be sufficient. Moreover, the transmembrane form of agrin 
would be mobile within the lipid bilayer whereas basal lamina associated agrin is highly 
immobile. 
The homology of agrin with the neurexins (i.e., presence of laminin-G-like domains) 
together with the synaptic localization of agrin suggests that it may have a similar function 
as the neurexins. The neurexins have recently been shown to be involved in the formation 
of presynaptic specializations in pontine or granular neurons in vitro (Scheiffele et al., 
2000). A very similar result has been obtained when the transmembrane form of rat agrin is 
presented to chick ciliary ganglia neurons (Campagna et al., 1995) and sensory dorsal root 
ganglia neurons (Chang et al., 1997). Thus, the transmembrane form of agrin may also 
serve as an adhesion molecule involved in modulating neurite outgrowth and presynaptic 
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differentiation in the CNS. Our finding that the transmembrane form of agrin is highly 
glycosylated indicative of a HSPG, further suggests a potentially similar function to the 
syndecans, a family of cell surface HSPGs (for review see Bernfield et al., 1999). 
Like agrin, syndecan-2 is enriched at neuron–neuron synapses (Hsueh et al., 1998). 
Moreover, syndecan-2 associates with the cytoplasmic adapter molecule CASK/Lin-2 
(Hsueh et al., 1998), which is thought to be important for localizing syndecan-2 to 
synapses. Interestingly, CASK/Lin-2 also associates with the neurexins (Hata et al., 1996). 
Thus, extracellular adhesion molecules thought to be involved in synaptic function are 
structurally related to agrin, the first bona fide inducer of postsynaptic structures at the 
NMJ. Although this correlation between syndecans, neurexins and agrin is only based on 
structural similarities, it raises the possibility that neuron-neuron synapses may use several 
different molecules related to agrin. This may also explain why agrin-deficient mice do not 
show a CNS phenotype (Serpinskaya et al., 1999; Li et al., 1999) as both the syndecans 
and the neurexins may compensate for the loss of agrin in this tissue. 
 
A Role of TM-Agrin as Receptor 
We show here that TM-Agrin is associated with the fiber tract of chick retinal ganglion 
cells at the time of active axonal elongation (Fig. 10). Thus, it seems possible that this form 
of agrin is involved in regulating axonal growth or pathfinding. Moreover, cell surface-
bound HSPGs, such as syndecans, have been shown to be important in the presentation of 
growth factors to their cognate receptors. This is particularly striking for the family of 
heparin-binding growth factors, like fibroblast growth factor (FGF) and HB-
GAM/pleiotropin. In view of our results presented here, TM-Agrin could also serve as a 
co-receptor for the presentation of such growth factors (for review see Bernfield et al., 
1999). In this context it is also interesting to note that signaling of the wingless (wnt) 
growth factors via the Frizzled2 receptor in Drosophila requires the proteoglycan dally 
(Lin and Perrimon, 1999; Tsuda et al., 1999). Moreover, one of the vertebrate homologues 
of wnt, Wnt-7A, has recently been implemented in presynaptic differentiation of granule 
cell neurons in the cerebellum (Hall et al., 2000). These data suggest that TM-Agrin could 
also serve as a co-receptor necessary for the signaling of such small growth factor-like 
molecules. 
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Although the cytoplasmic domain of agrin is only short and does not display significant 
homologies to previously characterized molecules, the detection of a transmembrane form 
of agrin opens the possibility that agrin is a receptor capable of transmitting an 
extracellular signal to the cytoplasm. This could be achieved by either a direct activation of 
the intracellular domain of agrin or via the recruitment of adapter molecules. The low 
degree of conservation between the cytoplasmic parts of chick and the mammalian 
homologues suggests that such a signaling/adapter function of TM-Agrin is less likely. 
Future experiments, such as selective inactivation of the transmembrane form, may be 
necessary to understand the role of this form during the development of the brain. 
 
Experimental Methods 
Animals 
Fertile White Leghorn (Gallus gallus domesticus) chicken eggs were purchased from a 
local hatchery and incubated at 38°C in a humid atmosphere. The stage of development 
was determined according to criteria de-fined by (Hamburger and Hamilton, 1951) and 
expressed as embryonic days of development (E). Mice were bred in-house and were 
derived from C57/BL6 strains. 
 
Antibodies 
The rabbit anti-agrin antiserum #46 reacts with all agrin isoforms and has been extensively 
characterized previously in Western blotting and immunocytochemistry (Kroger and 
Mann, 1996; Kroger et al., 1996; Kroger, 1997; Hering and Kroger, 1999). The anti-Islet-1 
monoclonal antibody (Mab 39.4D5; Ericson et al., 1992) developed by T. M. Jessell was 
obtained from the Developmental Studies Hybridoma Bank developed under the auspices 
of the NICHD and maintained by The University of Iowa (Department of Biological 
Sciences, Iowa City, IA 52242). Other primary antibodies used in this study were: anti-
chick agrin antisera (Gesemann et al., 1995), anti-c-myc monoclonal antibody 9E10 (Evan 
et al., 1985), and anti-alkaline phosphatase antibody (Medix Biotech Inc.). Appropriate 
secondary antibodies were all purchased from Dianova, Hamburg. 
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Cell Culture and Transfections 
Human embryonic kidney cells (HEK293; Graham et al., 1977), COS cells (Gluzman, 
1981), and primary chick myotubes were grown as described previously (Gesemann et al., 
1995). C2C12 mouse muscle cell lines were cultured as described by Briguet and Ruegg 
(2000). Cells were transfected with the DEAE-dextran-based method described elsewhere 
(Cullen, 1987). In some cases, FuGENE (Roche Diagnostics) applied according to the 
supplier was used for transfecting COS cells. 
 
Isolation of the 5’End Encoding the Transmembrane Form in Mouse and 
Chick 
Different tissues were dissected from newborn mice. Tissues (20 mg of kidney, 60 mg 
brain, spinal cord, and lung) were homogenized with a Polytron (Kinematica, Lucerne) in 
175 µl lysis buffer. After adding 175µl of RNA dilution buffer, the samples were incubated 
at -70°C for 3min and centrifuged at 13,000rpm for 5min. RNA was isolated to the 
manufacturer’s recommendation (RNeasy Minikit, Qiagen). RNA of all tissues was reverse 
transcribed using the primer asFS4 (5’-TGCAGGTCACATCGGCACAG-3’), which anneals to 
the sequence encoding the second FS domain of agrin. Touchdown PCR using Pwo 
polymerase (Roche MolecularBiochemicals, Mannheim, Germany) and the primers 
sXhoIShATG (5’-CTCGAGATGCCNCCNYTNCCNYTNGARCAY-3’), a primer designed from the 
amino acid sequence of rat agrin Rupp et al., 1991), and asBgIIIFS3 (5’-AGCT 
TAGATCTCCCACATGGCCCTTGGCGGAGT-3’) resulted in PCR products in all tissues. PCR 
products were subcloned into the EcoRV sites of pBluescriptII KS1 (Stratagene) and 
sequenced, generating pKS-TM. The 5’end of chick agrin was isolated by primerextension 
analysis using the SMART RACE cDNA amplificationkit (Clontech). Total RNA from 
brain and spinal cord of 6-day-old chicken embryos was isolated according to the 
manufacturer’s recommendation (RNeasy Minikit, Qiagen). First strand cDNA synthesis 
was initiated using the agrin-specific primer asccyA171 (5’-AAGAGCAGCAGAGCAAATCC-
3’) and the SMART II oligo (5’-AAGCAGTGGTAACAACGCAGAGTACGCGGG-3’). Reverse 
transcription was performed on 1µg RNA using SuperscriptII reverse transcriptase (Gibco 
BRL). After incubation at 42°C for 60min, 1µl of RNaseH (RocheDiagnostics) was added 
and incubation was continued for 20min at 37°C. The resulting cDNA fragments were 
amplified by PCR (PCR Advantage 2 Kit, Clontech) with the nested antisense primer 
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asccyA131 (5’-GGATGAGGCAAATGTTGCAC-3’) and the universal primer mix provided by 
the manufacturer. PCR fragments were analyzed on a 1% agarose gel, extracted from the 
gel (QIAEX, Qiagen), and cloned into the pGEM-TEasy vector (Promega). Individual 
colonies were grown and their inserts were sequenced. 
 
Generation of Expression Constructs 
Constructs to determine the orientation of agrin in transfected COS cells were made as 
follows. All constructs were cloned into the pBK-CMV vector (Stratagene). First, the 
human placental alkaline phosphatase (AP) gene (Berger et al., 1988), originating from 
theAPtag-1 expression vector (Flanagan and Leder, 1990) was inserted into pBK-CMV 
using the HindIII and XhoI sites giving rise to pBK-CMV-AP. All constructs described in 
this section were cloned into the HindIII and BglII sites of this mammalian expression 
vector, giving rise to C-terminal AP-fusion proteins. To construct a transmembrane version 
of mouse agrin, the transmembrane segment was removed from the pKS-TM (see above) 
by digestion with HindIII and BglII and cloned into the corresponding sites of pBK-
CMVAP. The Myc-TM-AP construct was cloned as follows. The 6 amino-terminal myc 
epitopes and a 5’leadersequence were obtained by digestion of the pCS2+MTvector (Roth 
et al., 1991) with HindIII and XhoI. The TM-fragment was generated by digestion of pKS-
TM with XhoI and BglII. Both fragments were then cloned into the HindIII and BglII sites 
of pBK-CMV-AP in a triple ligation. The SS-NTA-AP construct, containing the entire 
mouse SS-NtA, the first follistatin like domain (FS) and a C-terminally fused AP was 
generated by a series of RT-PCR on RNA isolated from PO mouse kidney and PCR on the 
genomic clone HB4. The resulting two PCR products were ligated into pBK-CMV-AP, 
yielding the final SS-NtA-AP construct. All constructs were verified by DNA sequencing. 
PCR conditions and DNA manipulations were done according to standard protocols, if not 
indicated otherwise. Full-length cDNA encoding the transmembrane form of chick agrin 
(TM-Agrin) was constructed by replacing the sequence encoding the 5’end of pcAgrin7A4B8 
(Denzer et al., 1995) by a PCR fragment isolated from the 5’RACE experiments described 
above. To remove most of the 5’untranslated region and to introduce an EcoRI restriction 
site, PCR was conducted using the primer EcoRI-5’ccyA_27 (5’-GCGAATTCACAGCATGAC 
GGCTTGCCA-3’) and the antisense primer agrin_as537 (5’-CGCACACCGCCCCGAACCCA-3’). 
The fragment was digested with EcoRI and XhoI and ligated to pcAgrin7A4B8∆UTR, an 
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expression construct whose 3’untranslated region had been removed. Because digestion of 
pcAgrin7A4B8∆UTR also removed an XhoI–XhoI fragment within the coding region of 
chick agrin, another ligation was necessary to reinsert this fragment. This was 
accomplished by XhoI digestion of the pcAgrin7A4B8∆UTR, isolation of the resulting agrin 
fragment and ligation to the construct from the previous ligation, cut with XhoI. The 
resulting construct pcTM-Agrin7A4B8∆UTR contained the entire open reading frame of the 
transmembrane form of neural agrin. 
 
Quantification of AP Fusion Proteins 
Two days after transfection of COS cells, conditioned medium was collected (sup), the 
cells were scratched off the culture dish and lysed in 1ml PBS, 1% TritonX-100. To 
inactivate the endogenous phosphatases, the cellular fraction and the supernatant were 
heated at 65°C for 5min. The fractions were subsequently centrifuged at 13,000rpm for 
2min. A 50-µl aliquot of every fraction was mixed 1:1 in a microtiter plate with the Sigma 
FAST p-Nitrophenyl Phosphate (Sigma) substrate for AP. The amount of AP was 
determined by measuring the OD405 every 5min during 1h (Labsystems Multiscan RC) 
and by determining the maximal slope of the curve ∆OD/µl min over four timepoints 
(Genesis 1.79, Lifesciences Ltd.). 
 
Staining of COS Cells, Metabolic Labeling and Immunoprecipitations 
Transfected COS cells were grown for 2 days in DMEM containing 10% FCS before 
staining. For the surface staining, the cells were precooled for 15min to 4°C. The medium 
was replaced by precooled medium containing either anti-human placenta AP monoclonal 
antibody (MedixBiotech Inc.; diluted 1:500) or anti-myc monoclonal antibody 9E10 (Evan 
et al., 1985; diluted 1:1000). The cells were incubated for 30min and washed with 
precooled medium. They were fixed with 4% paraformaldehyde (PFA), 11% sucrose in a 
0.1M potassiumphosphate buffer, pH7.2, for 30min at 4°C, followed by another 30min at 
room temperature (RT). Reactive groups in PFA were subsequently blocked with PBS 
containing 20mM glycine. To permeabilize the cells, they were incubated with PBS 
containing 0.1% saponin (PBSS) and10% normal goat serum (NGS) for 20min at RT. 
Appropriate FITC-conjugated antibodies were incubated for 1h in the dark at RT. After 
washing with PBSS, the cells were mounted with Citifluor (Plano) and examined with a 
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microscope equipped with epifluorescence (Leica, Nussloch, Germany). For intracellular 
staining, cells were fixed first for 30min with 4% PFA, 11% sucrose in 0.1M 
potassiumphosphate buffer, pH7.2. After two washes with PBS and PBSS, the cells were 
incubated for 20min with PBSS containing 10% NGS. Subsequently, they were incubated 
for 2h with the primary antibody, then rinsed with PBSS. The incubation with the 
secondary antibody and the analysis was performed as described above. The procedure to 
metabolically label agrin-transfected COS cells, was similar to that described elsewhere 
(Gesemann et al., 1995) except that COS cells were chased for 3h with medium 
supplemented with 10mM methionine before lysis. 
 
Real-Time Quantitative PCR 
For real-time quantitative PCR, the ABI PRISM 7700Sequence detector (PE Applied 
Biosystems) and the protocols supplied by the manufacturer were used. The following 
primers and probes were used for the different regions. 
SS-NtA region: 
sense primer: scNtA388 (5’-ACCCAGCCCCTCAGTACATGT-3’) 
antisense primer: ascNtA432 (5’-CATCAGGCTGGAGTTGAGCAT-3’) 
probe: (5’-FAMCCTGCCCACCGCAACGAGCTAMRA-3’) 
First FS-like region (TM-Agrin): 
sense primer: scFS146 (5’-CCAACGAGTGTGAGCTGGAGAAA-3’) 
antisense primer: ascFS293 (5’-GTCCCTTGCTGATGACCTTGA-3’) 
probe: (5’-FAMCCCAGTGCAACCAGCAGAGGCGTAMRA-3’) 
Transmembraneregion (TM-Agrin): 
sense primer: sccy-A166 (5’-TCATTGATCCCGTGCAACATT-3’) 
antisense primer: asccyA214 (5’-AGCAGCACAGCAAATCCCA-3’) 
probe: (5’-FAMCCTCATCCTCCTGGCCACCTCCATAMRA-3’) 
As internal standard, we used primers and probes for 
glyceraldehyde3-phosphate dehydrogenase (GAPDH): 
sense primer: GAPDH rev. (5’-GGGCACTGTCAAGGCTGAGA-3’) 
antisenseprimer: asGAPDH rev. (5’-GGTCACGCTCCTGGAAGATAGT-3’) 
probe: (5’-FAMatggcgtgcccattgatcacaagtttcTAMRA-3’). 
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To determine the relative amplification efficiency of PCR reactions for specific sequences 
encoding the first follistatin-like (FS) domain (pan-Agrin), the transmembrane region (TM-
Agrin), and the NtA domain (SS-NtA-Agrin), a construct was generated that comprised all 
three regions. Construct pcN257C21B8 (Meier et al., 1998a) and the subcloned PCR 
fragment from the primer extension analysis (see above) served as templates to generate 
this construct. pcN257C21B8 was digested with XbaI, blunt-ended with Klenow, and 
digested with EcoRI. This generated a fragment containing the entire pcDNA1 vector and 
the sequences encoding SS-NtA and the first FS-like region. The sequence encoding the 
transmembrane region was isolated from the subcloned PCR fragment from the primer 
extension analysis by ClaI digestion followed by Klenow-treatment and digestion with 
EcoRI. After gelpurification, the two fragments were ligated. Amplification efficiencies for 
individual sets of primers and probes were measured using different concentrations of the 
construct (0.05, 0.1, 0.2, and 5 ng). Relative amplification efficiencies were SS-NtA-Agrin 
= 0.93 X pan-Agrin and TM-Agrin = 1.3 X pan-Agrin. All the different tissues were 
dissected from embryonic 11-day-old chick embryos. Total RNA was isolated using a 
commercial kit (RNeasy Mini Kit, Qiagen). RNA was reverse transcribed using random 
primers and SuperscriptII (Gibco, BRL). To determine the relative amount of agrin mRNA 
in each tissue, mRNA encoding the house-keeping enzyme GAPDH was used for 
normalization. In all tissues, the relative abundance of agrin mRNA was similar which 
allowed use to set the amount of mRNA encoding pan-Agrin as 100%. Relative amounts of 
mRNA encoding the two agrin isoforms, TM-Agrin and SS-NtA-Agrin, were calculated by 
accounting for the amplification efficiencies of the different sets of primers. 
 
Characterization of the Mouse Agrin Gene 
In order to determine the genomic organization of the agrin gene a Bacterial Artificial 
Chromosome (BAC) mouse strain 129 library (Genome Systems, Inc.), kindly provided by 
Dr. R. Skoda (Biozentrum), was screened with probes against the NtA (NtA-probe1) and 
the TM-region of mouse agrin. The probes were labeled by PCR in the presence of 
[α32P]dATP (Amersham PharmaciaBiotech) and subsequently purified with NucTrap 
pushcolumns (Stratagene) according to the manufacturer’s protocol. The amount of labeled 
probe was determined by liquid scintillation counting (Packard Tri-Corb 2200CA). The 
NtA-probe1 was generated by PCR on mouse cDNA (see below) using the primer pair 
Chapter II  43 
sNA1 (5’-CACCACGTTCGCCTCCTCCT-3’) and asNA3 (5’-GGCCACCACATCTTTGC-3’) giving 
rise to a 128bps probe containing parts of the first two exons of the mouse NtA. The NtA-
probe2 (87bps), which contains only the first exon of the NtA, was generated by PCR with 
sNA1 and asNA2 (5’-CCTTGCAGGAGTAGGTGTG-3’). To obtain the 132-bp TM-probe, a 
PCR with the primers sSh1 (5’-ATGCCCCCGTTGCCTTTTGA-3’) and asSh3 (5’-
CAGCACCGCAAAGCCCAACG-3’) was performed. Before hybridization, the nitrocellulose 
filters of the BAC library were washed for 1h at 45°C in 15mMNaCl, 150mM sodium 
citrate, pH7 (2XSSC), containing 0.1% SDS. Subsequently, filters were prehybridized for 
2h at 37°C in 300ml in 5XSSC containing 5XDenhardt’s reagent, 48% deionized 
formamide and 100µg/ml salmon sperm DNA (hybridization solution). The labeled and 
denatured probe (approximately 108cpm) was incubated overnight at 37°C. Filters were 
washed three times at 45°C using 2XSSC containing0.1% SDS, wrapped into saran foil, 
and analyzed with the PhosphorImager 425 (Molecular Dynamics). One BAC contained 
the SS-NtA and the TM (Genome systemsclone no. 3/4/J3/130) and two other BACs 
contained only the TM domain (2/6/n23/96 and 4/2/b17/182). The BAC containing both 
sequences was subjected to further investigation. Fragments generated by restriction 
digestion were identified by Southern blot analysis with the described probes and 
subcloned into pKS (Stratagene). HB4, a 2.7kb long HindIII– BamHI-fragment, was 
identified with NtA-probe2. It represents the most 5’clone, containing parts of the 
5’UTRand the first exon. It is followed by the 4.2kb, BamHI cut fragment Bam8 that was 
recognized by the NtA probe1. The EcoN fragment is a 6.7kb-long EcoRI fragment 
covering most of the first intron and the second exon. The only fragment covering the 
second exon oft he NtA and the TM is the XhoI-cut product XhoNS, which hybridizes with 
NtA-probe1 and the TM-probe. It overlaps in the TM domain with the 6.5kb EcoRI, clone, 
EcoS, which overlaps with the published sequence (Rupp et al., 1992) at the 3’end. The 
described genomic clones were characterized by further restriction mapping and partial 
sequencing. Sequencing was performed using Big Dye AmpliTaq FS DNA sequencing kit 
(PerkinElmer) and ABI-Prism-System 377 and 310 (PerkinElmer). 
 
Generation of Anti-Peptide Antisera 
For immunization the peptide LICDNQVSTGDTRIFFVNPAP, corresponding to amino 
acid 96 to 116 of the chick NtA domain (Denzer et al., 1995) and the peptide 
Chapter II  44 
TACQYPMAPGALERDRLYQHKV, corresponding to amino acid 2 to 23 of the 
transmembrane form of agrin, were coupled to keyhole limpet hemocyanin via an 
additional N-terminal cysteine and injected into two sheep each. Approximately 100ml of 
the bleed from day 135 of the immunization were affinity-purified using the corresponding 
peptide coupled to CNBr-Sepharose 4B (Pharmacia, Freiburg, Germany). The eluted IgG 
appeared homogeneous in SDS–page analysis after silver staining. The IgG concentration 
of the affinity-purified antisera was measured using the Bio-Rad protein assay as described 
by the manufacturer (Bio-Rad, Munich, Germany). The antisera were used at a 
concentration of 5µg/ml for immunocytochemistry. 
 
Immunocytochemistry 
Staining of E6 chick retinae was performed as described previously (Kroger et al., 1996). 
Stained sections were investigated using the appropriate wedge-corrected fluorescence 
filter sets. In preparations stained with only the one primary or only the one secondary 
antibody, no signal was detected in the corresponding other channel, indicating the 
specificity of the fluorescence and an absence of cross-bleeding. Preincubation of the 
antisera with the peptide used for the immunization strongly reduced the 
immunofluorescence, demonstrating the specificity of the signal. The corresponding 
preimmune sera gave no specific staining. Images were taken with a cooled CCD camera 
(Spot 2, VisitronSystems, Puchheim, Germany). Brightness and contrast of the images 
were adjusted using Adobe Photoshop5.5. 
 
Analysis of Agrin in Retinal Ganglion Cells 
Retinal ganglion cells were purified from E6 chick retina by immunopanning with the anti-
Thy-1 antibody (generously provided by Peter Jeffrey and A. Rodriguez-Tebar) as 
previously described (Barres et al. 1988) with the following modifications: Petridishes 
were coated with goat anti-mouse IgG (Dianova, Hamburg, Germany; 23µg/ml final 
concentration) overnight at 4°C and subsequently coated with the mouse anti-chick Thy-1 
monoclonal antibody (Sinclair et al.,1987) ascites fluid diluted 1:1000 in PBS containing 
1mg/ml d-glucose, 0.036 mg/ml sodium pyruvate (DPBS),supplemented with 0.2% BSA. 
Chick retinae were dissociated by incubating six pigment epithelium-free retinae in 10ml 
D-PBS, containing 80 units papain (Worthington/Technicon, Bad Vilbel Germany) and 
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1000 units DNase (Sigma, Deisenhofen, Germany). Proteolytic digestion was stopped by 
adding ovomucoid and the tissue was triturated as described by (Barres et al., 1988). The 
single cell suspension was then added to the coated petridishes and incubated 45min at RT 
with gentle agitation. Afterwards, the plates were washed 10 times with D-PBS and the 
panned cells were released by trypsinisation in 0.125% trypsin (Sigma). Cells were 
collected by centrifugation at 900g for 15min. Only a single panning step was necessary in 
the avascular E6 chick retina. Analysis of the purified fraction with the anti-Islet-1 
antibody, a specific marker for retinal ganglion cells (Austin et al., 1995), revealed that the 
ganglion cells were more than 97% pure after a single panning step. RNA was isolated 
from the panned ganglion cells and from total retinal cells using the GlassMAX RNA 
isolation system (LifeTechnologies, Karlsruhe, Germany). Messenger RNA from total 
retina from different developmental stages was isolated using the Ultraspec reagent 
(Biotecx Laboratories, Houston, TX). Complementary DNA was synthesized from 1µg 
(panned cells) or 5µg (total retina) mRNA after DNase digestion using 5units DNaseI (Life 
Technologies) using oligo dT10-primers and random primers (0.5µM each, Boehringer–
Mannheim, Germany), dNTPs (0.5mM each; Boehringer), DTT (10mM; Life 
Technologies), RNase inhibitor (100units; Boehringer), and SuperscriptII reverse 
transcriptase (1000 units, Life Technologies). PCR reactions were performed using the 
following primers: 
NtA domain first PCR: 
Sense primer: NTAF12 (5’-CTGGGGTTTGGCGCTGGGATTGG-3’) 
antisense primer: NTAB1 (5’-GGGTCGGCGGGGTCTGGGTAAA-3’); annealing temperature 
63°C 
Semi-nested PCR for the NtA domain: 
Sense primer as in the first reaction 
antisense primer: NTAB2 (5’-CATGTACTGAGGGGCTGGGTTGAC-3’); annealing temperature: 
61°C 
The transmembrane form of agrin was identified by a similar nested PCR approach. The 
first round of PCR was performed using the following primer pair: 
TMF1 (5’-TCTCCTGGTGGTGCGCTACTTCA-3’) 
TMB1 (5’-AGGGGTCGCAGGCTCCATCAAACT-3’); annealing temperature: 62°C) 
The second nested PCR was performed using the following primer pair: 
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TMF2 (5’-CTGGGATTTGCTGTGCTGCTCTTC-3’) 
TMB2 (5’-CTCGCTGCGGTAGTCCTT-3’); annealing temperature: 59°C) 
The PCR reaction products were separated on 3% Tris-borate-EDTA agarose gels and 
stained in 2.5µg/ml ethidium bromide. Two types of controls were analyzed to exclude the 
presence of contaminating DNA: a nested PCR on an aliquot of the first PCR in which 
water was added instead of cDNA (lanes C1 in Figs. 9B and 9C) and a PCR with only the 
nested primers, but with water instead of cDNA (lanes C2 in Figs. 9B and 9C). In all cases 
the PCR products were subcloned into the TOPO cloning kit (Invitrogen) and at least three 
randomly chosen clones were sequenced. 
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Chapter III 
Transmembrane Agrin Reorganizes the Cytoskeleton in 
Neurons and Non-Neuronal Cells 
Introduction 
Agrin is widely expressed in the central (CNS) and in the peripheral nervous system 
(PNS), in neuronal as well as in non-neuronal tissue. Agrin’s function is best understood in 
skeletal muscle where it plays a key role during formation, maintenance and regeneration 
of the NMJ (for review seee Sanes and Lichtman, 2001; Bezakova Ruegg, 2003). Its role in 
other tissues, in particular the CNS is still poorly understood and very little is known (for 
review see Kroger and Schroder, 2002). Although CNS neurons from mice with a targeted 
deletion of the agrin gene form normal synaptic specializations in vitro and in vivo (Li et 
al., 1999; Serpinskaya et al., 1999), the acute suppression of agrin expression or function 
by antisense probes or antibodies influences the formation and function of synapses (Bose 
et al., 2000). The suppression of agrin expression results in the impairment of dendritic 
development and the formation of less synapses than in non-treated or sense-treated 
neurons. 
Due to morphological and physiological similarities between nerve-muscle and the nerve-
nerve synapse it was assumed that the role in synapse formation might be analogous. 
Several studies addressed the question of the involvement of agrin and its task in the CNS, 
in neurite differentiation and outgrowth, and there is mounting evidence that agrin is a 
critical determinant in neuronal differentiation (for review see Smith and Hilgenberg, 
2002). Agrin isoforms are highly expressed by CNS neurons before synaptogenesis, 
suggesting additional functions for agrin during axonal elongation (Annies and Kroger, 
2002; Halfter et al., 1997; Kroger, 1997; Kroger et al., 1996; Mantych and Ferreira, 2001). 
However, agrin’s precise role during development of the CNS remains to be clairified. 
Alternative first exon usage results in the synthesis of either a secreted form (SS-NtA-
Agrin) or a transmembrane form of agrin (TM-Agrin). These isoforms are differentially 
expressed. While SS-NtA-Agrin is ubiquitously expressed in most basal lamina containing 
tissues, transcripts encoding TM-Agrin are preferentially enriches in the CNS, particularly 
on neurites during the phase of active neural growth (Burgess et al., 2000; Neumann et al., 
2001; Annies and Kroger, 2002). 
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In developing central neurons agrin is localized in axons, growth cones and at synaptic 
sites, where it may regulate differentially axonal and dendritic elongation. Neurons grown 
on cells expressing different isoforms of agrin develop shorter axons but exhibit more 
arborization. On the other hand agrin induces longer dendrites with more braches than in 
agrin-depleted neurons. Those changes are associated with changes in composition of the 
cytoskeleton (Mantych and Ferreira, 2001). Agrin provokes and regulates neuro-specific 
genes that are involved in neurite elongation and branching. At nearly every phase of brain 
morphogenesis agrin is expressed (Cohen et al., 1997; Ferreira, 1999; Mann and Kroger, 
1996). 
Thus agrin in the CNS seems to have alternate functions than it has in the development of 
the NMJ and it may be an important regulator of the maturation of dendrites and of 
synaptogenesis of neurons in the CNS. 
The identification of the transmembrane form of agrin has led to the hypothesis that this 
isoform might serve as a receptor with signal-transducing activity (Neumann et al., 2001). 
To verify this hypothesis, it has to be taken into consideration that the HSPG agrin is 
highly glycosylated and that it has two glycosaminoglycan (GAG)-attachment sites. A 
heparan sulphate proteoglycan is attached at serine/glycine (S/G)-clusters located between 
the 7th and 8th follistatin-like domain. At the centrally-located serine-threonine-rich domain 
there is a chondroitin sulphate-side chain (Winzen et al., 2003). 
These regions are involved in binding to neural-cell adhesion molecule (NCAM) and to 
heparin-binding growth factors, proteins involved in neuronal growth and development 
(Cole and Halfter, 1996; Cotman et al., 1999). Agrin is able also to inhibit neurite 
outgrowth via glycosaminoglycan (GAG) chains (Baerwald-De La Torre et al., 2004; 
Bixby et al., 2002). 
To test for the function of agrin in neurite outgrowth and to narrow down the responsible 
region, several non-neuronal cell lines (PC12, COS, HEK293) and primary hippocampal 
neurons were transfected with cDNA encoding cTM-Agrin. The protein induced the 
formation of actin-containing protrusions extending from the transfected cells. To address 
the question which part of the protein is necessary to induce these morphological changes, 
different chimeric constructs were generated where parts of the protein were replaced. 
While the intracellular and the transmembrane domains of TM-Agrin were dispensable for 
the formation of these processes, we show that the GAG side chains of TM-Agrin together 
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with close association of agrin with the plasma membrane are necessary and sufficient for 
the formation of these protrusions. Transfection of primary hippocampal neurons with TM-
Agrin also results in changes of the morphology, as agrin, expressed in either axons and 
dendrites induced the formation of microprocesses. To address the question of agrin as a 
receptor, we took advantage of the fact that most receptors with a single transmembrane 
region can be activated independently of their ligands by dimerization or oligomerization 
using polyclonal antisera (Heldin, 1995; Weiss and Schlessinger, 1998). Anti-agrin 
antibodies were used to cluster agrin on primary hippocampal neurons. We demonstrate 
that anti-agrin antibody-mediated oligomerization of TM-Agrin induces extensive changes 
in the axonal cytoskeleton of neurons as well as in transfected non-neuronal cells, resulting 
in the extension of numerous actin-containing processes. Microspikes appeared within 
minutes after antibody addition, contained a complex cytoskeleton and could be induced 
on neurons from the PNS and CNS. Time-lapse video microscopy revealed that 
microspikes were highly dynamic and were formed from growth cones that transiently 
extended from the axon shaft and adhered to the substrate, but were subsequently retracted. 
Taken together, these results support the hypothesis that TM-Agrin can serve as a receptor 
and suggest a role of TM-Agrin during axonal elongation or axonal branching in the 
developing CNS. 
 
Materials and Methods (Non-Neuronal Cells) 
Generation of Expression Constructs 
pcTM-Agrin 
The cDNA sequence for cTM-Agrin (c=chick) have been described elsewhere (Neumann 
et al., 2001). Chimeric constructs were generated where domains of the protein were 
exchanged and replaced by similar domains of other proteins. All constructs were cloned 
into the vector pcDNAI (Invitrogen; p = cloned into pcDNAI). All constructs were 
routinely sequenced to eliminate the possibility of mutations. 
 
pmyc.cTM-Agrin 
The cytoplasmic part of full-length cTM-Agrin was replaced by myc. A polymerase chain 
reaction (PCR) on the plasmid p_myc (Jones et al., 1999) was performed with the sense 
primer sEcoRI_myc: 
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(5’-GCTGGAATTCGGATCCCAGTCGACTCTAGAGGAAGTGGTAAAGCT-3’) 
and the antisense primer asBspHI_myc: 
(5’-CGGTCATGAACCCGAGGTCGCCCAAGCTCTCCATTTCATTCAAGT-3’) 
to obtain the myc-tag flanked by an EcoRI- and a BspHI-restriction site. The PCR product 
and pcTM-Agrin was cut with the restriction enzymes EcoRI and BspHI (both from NEB). 
The cytoplasmic part was cut out and replaced by myc. 
 
pmyc.cTM.Nsk2.ECD.His 
The cytoplasmic and the extracellular part were exchanged, the cytoplasmic part by myc 
and the extracellular part by the extracellular domain of the transmembrane protein Nsk2 
(dissertation Dominik Hauser). First, the NheI- and the HindIII-restriction sites were 
introduced by PCR on pmyc.cTM-Agrin with the sense primer T7: 
(5’-TAATACGACTCACTATAGGG-3’) 
and the antisense primer as_NotI_cTMdomain: 
(5’-GATGCGGCCGCGAGGAAGAGCAGCACAGCAAATCCCAGCGTGGAGG-3’) 
The PCR product was subcloned into the TOPO-vector (Stratagene). Using the restriction 
sites NheI/ HindIII, the insert was cloned into the vector pCEP-Pu (Kohfeldt et al., 1997). 
In order to replace the extracellular part of cTM-Agrin by the extracellular domain (ECD) 
of Nsk2, the insert was cloned into the pCEP-Pu-vector containing myc and TM-domain of 
agrin. The myc.cTM.Nsk2.ECD.His insert was ligated into the pcDNAI-vector using 
BstXI/ XhoI. 
 
pcTM(ASGP-R)-Agrin 
This construct was generated to exchange the TM-domain of agrin by the transmembrane 
domain of asialoglycoprotein receptor (ASGP-R; kindly received by M. Spiess; Spiess and 
Lodish, 1985). Several PCRs were necessary to create this construct. The first PCR was 
performed on ASGP-R to isolate the transmembrane domain and to introduce a BspHI site 
at the 5’end with the sense primer Pr3.BspHI_ASGP-R/TM-Agrin: 
(5’-ACTTCATGATCCTCCTCCTGCTCTCCCTG-3’) 
and the antisense primer Pr4.ASGP-R/TM-Agrin: 
(5’-ATAGCTATTGGGCTTGTAGTTGATCACACAGACAACCACAAG-3’) 
A second PCR on pcTM-Agrin was made with the sense primer Pr1.ASGP-R/TM-Agrin: 
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(5’-TTGTGGTTGTCTGTGTGATCAACTACAAGCCCAATAGCTATT-3’) 
and the antisense primer Pr2.BssHII_TM-Agrin: 
(5’-agcagcgcgccgtgcca-3’) 
These two PCR fragments (809bps and 89bps) were purified and used as templates for the 
following overlapping PCR. The short fragment was loaded on 4% MethaPhor agarose 
(BMA) and extracted with phenol-chloroform method. The overlapping PCR was 
performed with the sense primer Pr3.BspHI_ASGP-R/TM-Agrin: 
(5’-ACTTCATGATCCTCCTCCTGCTCTCCCTG-3’) 
and the antisense primer Pr2.BssHII_TM-Agrin: 
(5’-AGCAGCGCGCCGTGCCA-3’) 
The obtained PCR product was digested with BspHI and BssHII. To overcome the dam-
methylation problem of the BspHI-site in pcTM-Agrin, an additional PCR on the latter 
construct was carried out with the sense primer T7pcDNAI: 
(5’-TAATACGACTCACTCTAGGG-3’) 
and the antisense primer ascyA131: 
(5’-GGATGAGGCAAATGTTGCAC-3’). 
This PCR product was cut with EcoRI and BspHI. pcTM-Agrin was digested with EcoRI 
and BssHII. The PCR product, and the last PCR fragment were cloned via triple-ligation 
into the digested pcTM-Agrin. 
 
pcTM-PF9 
This construct is a shortened version of the cTM-Agrin∆ST1-G3 (kindly received from 
Stephan Kröger). It has a GAG attachment site between the 7th and 8th FS domain. The 
5’end of cTM-Agrin∆ST1-G3 was cloned into pcDNAI (Invitrogen) using HindIII and PstI. 
The cDNA coding for the 8 FS-domains was cut out from cTM-Agrin∆ST1-G3 and added to 
the 5’end already in the vector using PstI. The correct of the insert orientation was checked 
by restriction digests. 
 
pcTM-9Mc 
This construct derives from 9Mc (kindly received from Willi Halfter; Winzen et al, 2003). 
It is composed of the 8 FS-domains of agrin. The three serines (S) from the SG-clusters 
between the 7th and 8th FS-domain are mutated to alanines (A). In order to add the DNA 
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sequence at the 5’end that codes for the cytoplasmic part of agrin and the TM-domain 
following procedure was performed: The 5’end of cTM-Agrin∆ST1-G3 was cloned into 
pcDNAI using HindIII and PstI. The mutated 3’end was cut out from 9Mc and added to 
the 5’end already in the vector using PstI. The right orientation of the insert was confirmed 
by restriction digest. 
 
Cell Culture 
PC12 cells, a neuron-like cell line, were grown in DMEM high glucose (Gibco) 
supplemented with 5% FCS (Gibco), 10% HoS (Gibco), 0.11mg/ml sodium pyruvate 
(Gibco), 0.292mg/ml L-Glutamine (Gibco), 100U/ml Penicillin (Gibco), 100U/ml 
Streptomycin (Gibco). For human embryonic kidney cells (HEK293; Graham et al., 1977) 
the same medium was used supplemented with 10% FCS. 
 
Transfection 
Cells were first grown and cultured in 15cm tissue culture dishes. Before transfection they 
were plated with the density of 100’000 cells/ well in 4-well glass-slides that were coated 
overnight (oN) with poly-L-lysine (MW: 30’000-60’000 dissolved at 1mg/ml in 0.1M 
borate buffer; Sigma). After 24h, cells were transfected with jetPEI (Q-Biogene). The 
procedure followed the jetPEI protocol using 3µg plasmid DNA and 6µl transfection 
reagent pro well. PC12 were then treated with neural growth factor (NGF) to induce 
differentiation. After 24-48hs, cells were stained with appropriate antibodies (see below). 
 
Antibodies 
The following primary antibodies were used: 
 
pNsk2 rabbit anti-mouse Nsk2 #194 (1:1000) 
recognizes ECD of Nsk2 
unpubl., Ruegg MA 
cTM-Agrin rabbit anti-chick #3228 (1:1000) 
recognizes carboxy-terminal part of chick agrin
 
Ruegg, MA 
 
SS-NtA-Agrin rabbit anti-chick #3228 (1:1000) 
recognizes carboxy-terminal part of chick agrin
 
Ruegg, MA 
 
myc.cTM-Agrin rabbit anti-chick #3228 (1:1000) 
recognizes carboxy-terminal part of chick agrin 
Ruegg, MA 
 
myc.cTM.Nsk2.ECD.His rabbit anti-mouse Nsk2 #194 (1:1000) 
recognizes ECD of Nsk2 
unpubl., Ruegg MA 
cTM(ASGP-R)-Agrin rabbit anti-chick #3228 (1:1000) 
recognizes carboxy-terminal part of chick agrin
 
Ruegg, MA 
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cTM_PF9 rabbit anti-chick #706 (1:500) 
recognizes FS domains
 
unpubl., Ruegg MA 
cTM_9Mc rabbit anti-chick #706 (1:500) 
recognizes FS domains 
 
unpubl., Ruegg MA 
When applicable, antibodies against the intracellular part of cTM-Agrin (sheep anti-TM-
Agrin; (Neumann et al., 2001) were used to verify cTM-Agrin expression. 
 
The following secondary antibody was used: 
 
cy3-labeled goat anti-rabbit IgG (1:1000) Jackson Laboratory 
 
Immunocytochemistry 
Transfected cells were washed twice with prewarmed PBS (phosphate-buffered saline) and 
then fixed with 4% PFA (paraformaldehyde) for 30min at RT (room temperature). Cells 
were again washed twice with PBS and twice with PBS containing 20mM glycine. 
Subsequenquently cells were incubated oN at 4°C with the primary AB (antibody), diluted 
in PBS containing 10% NGS (normal goat serum; Gibco). Next, cells were washed with 
PBS containing 10% NGS and permeabilized for 30min at RT with PBS containing 10% 
NGS and 1% saponin (Sigma). The secondary AB, diluted in PBS containing 10% NGS 
and 1% saponin was then added for 1h at RT in the dark. Alexa-488-labeled phalloidin 
(1:500; Molecular Probes) was used to visualize the cytoskeleton. Staining of the nuclei 
was achieved with DAPI (1µg/ml; Sigma). After washing with PBS containing 10% NGS 
and 1% saponin cells were mounted on glass slides and then examined under the 
fluorescence microscope. 
Formation of processes was analyzed after fixation and staining. For quantification, only 
solitary cells were evaluated. Cells were scored “process-containing” in case they had 
more than 10 processes with a length of more than the cell’s diameter. Results are given as 
mean +/- SEM with N=3.  
 
Materials and Methods (Neuronal Cells) 
Preparation of Mouse Primary Hippocampal Cultures 
The coverslips were cleaned by incubation oN with HNO3 and followed by two washes 
with NP (nanopure) H2O and two washes with absolute EtOH for 30min each. For 
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sterilization, they were baked at 240°C oN. One day before plating, coverslips were coated 
with poly-L-lysine. After this preparatory work, pregnant mice were sacrificed by cervical 
dislocation. The hippocampi of E18.5 embryos were isolated and collected in 9ml 
precooled HBSS (Hank’s Balanced Salt Solution; Gibco). Hippocampi were then treated 
with 1ml Trypsin/ EDTA (Gibco) and incubated in the waterbath at 37°C for 15min. The 
tissue was washed by fresh HBSS and replaced with 10ml MEM (Minimum Essential 
Medium) with Glutamax (Gibco) containing 10% FCS and 1% of P/S (Penicillin/ 
Streptomycin). Subsequently, cells were dissociated by pipetting smoothly (!). For staining 
of endogenous protein or for incubation experiments with the primary AB, the cells were 
plated at a density of 5-7.5 X 104 per coverslip. For transfection experiments cells were 
plated at a density of 15-20 X 104. The plating medium was MEM. Three hours later, when 
cells were attached on the coverslips, MEM was replaced with 1ml/well NBM 
(Neurobasalmedium; Gibco) containing 1% P/S, 0.5mMGln (Glutamine; Gibco), 
25µMGlu (Glutamate; Gibco) and 2% B27 (Invitrogen). After three days in vitro (DIV) 
NBM was replaced with fresh NBM without Glu. Primary neurons were then stained or 
transfected at different time points. 
 
Transfection of Primary Neurons 
Primary Hippocampal neurons in a cell density of 15-20 X 104/ml were transfected the 
4.DIV. The medium was replaced by 800µl of fresh NBM containing 0.5mM Gln and 2% 
B27. Transfection was performed with the transfection reagent Lipofectamine2000 
(Invitrogen). The protocol was followed, using 3µg of cTM-Agrin plasmid DNA and 4µl 
Lipofectamine per well. As negative control and as control for the transfection efficiency 
an EGFP-construct (Invitrogen) was used. 
 
Antibodies 
The following primary antibodies were used: 
 
mTM-Agrin rabbit anti-mouse #204 (1:1000) 
recognizes 
Eusebio et al., 2003 
cTM-Agrin rabbit anti-chick #206 (1:1000) 
recognizes 
Unpubl., Ruegg, MA 
MAP2 in dendrites chicken anti-MAP2 (1:200) 
50µl in 10ml 3%BSA in PBS 
dendritic marker 
abcam 
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synaptophysin mouse anti-synaptophysin (1:1000) 
presynaptic marker 
Chemicon 
neurofilament rabbit anti-mouse NF (1:500) NovoCastra 
 
The following secondary antibodies were used: 
 
cy3-labeled goat anti-rabbit IgG (1:1000) Jackson Laboratories 
cy5.5-labeled goat anti-chicken (1:1000) abcam 
Alexa-488-labeled goat anti-mouse (1:1000) NovoCastra 
 
Immunocytochemistry 
Non-transfected as well as transfected neurons were stained the 6., 10. and the 14. DIV. 
Cells were washed twice with PBS-1 (PBS with 120mM sucrose) and then fixed with FS 
(fixation solution: 4% PFA in PBS-1) for 30min at RT. After fixation, cells were washed 
twice with PBS-1 and twice with PBS-2 (PBS with 20mM glycine and 10nM sodium 
azide). For permeabilization, cells were incubated in PS (permeabilization solution: 0.25 
Triton X-100 in PBS) for 10min at RT. After washing in PBS-1 cells were incubated in IN 
(incubation solution: 10 % BSA in PBS) for 60min in the incubator at 37°C. The 
incubation with the primary AB in AK (3 % BSA in PBS) was continued oN at 4°C. Next, 
cells were washed with PBS-1 and incubated with the secondary AB in AK for 60min at 
RT in the dark. For visualization of the actin cytoskeleton, Alexa-488-labeled phalloidin 
(1:500; Molecular Probes) was used and for the staining of the nuclei we used DAPI 
(1µg/ml; Invitrogen). 
 
Induction of Microspikes with Antibodies 
Before the staining procedure, microspikes were induced on hippocampal primary neurons 
by adding the primary antibody rabbit anti-mouse agrin #204. Neurons were incubated in 
early stage of development (5.DIV – before synapse formation) and at a later timepoint 
(10.DIV – during synapse formation). Incubation lasted 3hs in the incubator at 37°C. The 
AB was affinity purified using protein A and was then used at a final concentration of 
10µg/ml or 50µg/ml. After treatment with AB, cells were stained against neurofilament, to 
visualize the dimension of the neuron. The number of microspikes was determined in 
double-blind experiments by counting the total number of microspikes in an axon segment 
with a length of 110 µm. At least 10 segments were scored in each of three independent 
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experiments. Microspikes on both sides of the axon were counted, but the individual 
branches of single microspikes were not scored. 
 
Results 
TM-Agrin Reorganizes the Cytoskeleton of non-Neuronal Cells 
TM-Agrin was discovered as a highly glycosylated HSPG like the secreted isoforms but in 
contrast, as a protein that is predominately expressed in the CNS (Neumann et al, 2001). 
This was the reason for expression experiments in PC12 cells, a neuron-like cell line. The 
interest in this work was to analyse the expression in non-neuronal and neuronal cells. 
PC12 cells, neuron-like cell line, were transfected with full-length cTM-Agrin (C). They 
showed striking changes of morphology and an extension of microprocesses. Expression of 
SS-NtA-Agrin in parallel cultures, had no effect on the morphology of the transfected cells 
(B). In contrast, expression of the TM-Agrin induced a dramatic change in the morphology 
of the transfected cells. Transfection with Nsk2, also transmembrane protein with one TM 
domain, did not result in the formation of more processes compared to untransfected cells 
(A). 
 
A  B  C  
 
Fig. 11: PC12 cells transfected with cTM-Agrin (A), SS-NtA-Agrin (B) and Nsk2 (C) 
Transfection of the neuron-like PC12 cells with cTM-Agrin results in the formation of long microprocesses in contrast to the transfection 
with the secreted SS-NtA-Agrin or with the transmembrane protein Nsk2. 
 
The following transfection experiments were performed in HEK293 cells, because they 
showed the same alterations as PC12 cells upon transfection, and they were easier to 
handle. Quantification showed that more than 85% of the cells transfected with the TM-
Agrin cDNA had extended processes containing actin filaments. Cells transfected with the 
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control cDNA of SS-NtA-Agrin and Nsk2 respektively did not exhibit the described 
morphological changes. Thus the formation of microprocesses is a characteristic feature of 
TM-Agrin. 
 
A  B  C  
 
Fig 12: HEK293 cells transfected with cTM-Agrin (A), SS-NtA-Agrin (B) and Nsk2 (C) 
HEK293 cells transfected with cTM-Agrin form long protrusions in contrast to the controls. Cells are stained for agrin (red), for actin 
with phalloidin (green) and for the nuclei (blue). 
 
These data show that TM-Agrin is able to influence the cytoskeleton of non-neuronal cells, 
and that the effect on cell morphology is independent of the species of transfected cells. To 
determine whether protrusions contained cytoskeletal elements, they were stained with 
fluorescent Alexa-488-labeled phalloidin to reveal the actin filaments. The observation that 
transfection with TM-Agrin results in changes of phalloidin staining compared with the 
controls, led to the conclusion that this agrin isoform induces complex modifications of the 
cytoskeleton. 
 
The Extracellular Part of TM-Agrin is Required and Sufficient for Process 
Formation 
In order to determine the region involved in the induction of process formation, several 
chimera constructs were designed and expressed in HEK293 cells. Formation and 
extension of processes were quantified and expressed as percentage of process-containing 
cells per total number of transfected cells with the criteria described. Deletion and 
replacement of the intracellular domain of cTM-Agrin with myc-tag (C) did not abolish the 
process-inducing activity, indicating that the intracellular 35 amino acids are not required. 
85% of the transfected cells show changes in morphology. Next followed a construct 
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where only the TM-domain of agrin was left, the cytoplasmic part of this chimeric TM-
protein was the myc-tag and the extracellular part was substituted by the corresponding 
sequence of Nsk2 (D). In this case, only about 10% of the transfected cells featured 
microprocesses, suggesting that the TM-domain alone is not sufficient. The following 
construct was designed to figure out whether the TM-domain would be necessary for the 
modification of the cytoskeleton. Therefore this domain was replaced by the TM-domain 
of asialoglycoprotein-receptor, also a type II transmembrane protein (E). Transfection of 
HEK293 cells with this construct also resulted in the formation of microprocesses. This is 
conclusive evidence that the transmembrane region is not essential for these tremendous 
structural changes. 
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Fig. 13: Domain structures of different chimeric constructs 
(A) This is the secreted isoform that binds to laminin. (B) This is the TM-Agrin that is stabilized in the membrane. (C) The intracellular 
part is replaced by myc.tag. (D) Only the TM domain derives from agrin, the intracellular part is the myc-tag, the extracellular region is 
the extracellular domain of Nsk2. (E) The TM domain is replaced by the TM domain of asialoglycoprotein-receptor. (F) Shortened 
version of agrin with a GAG chain attached between the 7th and 8th FS domain. (G) In this construct three serines are mutated to alanines 
so that GAG chain can not attach. 
 
In summary, these data indicate that the intracellular part and the transmembrane domain 
of TM-Agrin are dispensable for the formation of microprocesses and suggest a crucial 
role for the extracellular part of TM-Agrin. Since the extracellular region of TM-Agrin is 
identical to the corresponding sequence in SS-NtA-Agrin, these results suggest the 
necessity of a close association of agrin with the membrane for the process-inducing 
activity. The close association of the extracellular part of TM-Agrin with the membrane is 
indispensable and sufficient for the process-inducing activity. Those data established the 
importance of the extracellular domain of TM-Agrin. 
To determine the precise region within the extracellular domain, the C-terminal region of 
TM-Agrin was successively shortened. Deletion of the C-terminal half of agrin, a region 
which contained three LG domains and four EGF-like domains and which is necessary and 
sufficient for agrin’s synaptogenic activity at the neuromuscular junction (Gesemann et al., 
1995), did not influence the ability to induce processes after transfection of HEK293 cells. 
Additional deletion of the two S/T-rich regions as well as the SEA module did not 
influence the process-inducing activity of TM-Agrin. In contrast, deletion of the 7th and 8th 
FS domain resulted in a complete loss of the process-inducing activity. This suggests that 
either the two FS domains or the GAG side chains, which are attached to the protein 
backbone between the 7th and 8th FS domain, might be responsible for the induction of 
processes in transfected cells. Transfection of cells with a shortened construct, containing 
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the intracellular part, the TM-domain and the 8 FS domains (F), results in the formation of 
microprocesses. Expression of a construct in which the GAG attachment site is mutated, 
serines in the three SG-clusters are mutated to alanines (Winzen et al., 2003), did not result 
in the formation of processes. These results suggest that the GAG side chains of agrin 
localized between the 7th and 8th FS domain play a crucial role in the formation of 
processes. 
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Fig. 13: Quantification of number of microprocesses 
Result from this quantification is that the TM-domain of agrin is not sufficient for the induction of microprocesses. This region of the 
protein seems to be only necessary for the fixation of the protein in the membrane. The GAG-chain between the 7th and 8th FS domain is 
then closer to the membrane. 
 
Microprocesses Form on Axons and Dendrites in the CNS 
For a better understanding of the function of TM-Agrin in the brain, the full-length protein 
was expressed in mouse primary hippocampal neurons of E18.5. In a first step neurons 
were transfected and immunostained after 6, 10 and 14 DIV. The protein was expressed in 
axons as well as in dendrites. Dendrites could be distinguished from the axons by staining 
against MAP2, a dendritic marker. Agrin was stained with the rabbit anti-chick agrin 
antibody #228. Transfection of neurons results in changes in the cytoskeleton, after 10 and 
much more the 14 DIV. To confirm the assumption that the actin skeleton changed, 
neurites were stained with Alexa-488-labeled phalloidin to reveal the actin filaments. Non-
transfected neurons, where the endogenous agrin was stained with the rabbit anti-mouse 
agrin #204 showed no morphological changes. 
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Fig. 14: Untransfected neurons (A), transfected neurons 6. (B), 10. (C) and 14. DIV (D) 
In contrast to untransfected cells, neurons change their shape, when transfected with TM-Agrin.  
 
The discovery of structure and intracellular localization of TM-Agrin led to the hypothesis 
that is might be a receptor or co-receptor capable of signal transduction across the 
membrane. It could be necessary for the signalling of small growth factor-like molecules. 
We took advantage of the knowledge that most if not all receptors with a single membrane 
spanning region can be activated by dimerization or oligomerization via an appropriate 
antibody, independently of the physiological ligand (Heldin, 1995; Weiss and 
Schlessinger, 1998). Primary non-transfected neurons were incubated with the affinity 
purified rabbit anti-mouse agrin antibody #204. It has already been shown that E6 RGCs 
exclusively express the transmembrane form of agrin and that this form is present on the 
surface of growing axons in vivo and in vitro (Kroger et al., 1996; Kroger, 1997; Hering 
and Kroger, 1999; Neumann et al., 2001; Annies and Kroger, 2002). Furthermore it was 
found that addition of antibodies to RGC cultures dramatically changed the shape of axons. 
The treatment with antibodies resulted in a stronger effect than seen in transfected neurons.  
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Fig. 15 Primary neurons after treatment with polyclonal antibodies 
Primary neurons that are treated with antibodies grow more curvy and form many fine processes. 
 
Anti-neurofilament antibody was used to visualize the extension of the neuronal cell. The 
actin cytoskeleton was labeled with Alexa-488 phalloidin. While untreated control neurons 
had a smooth surface and grew rather straight, neurites treated with antibodies exhibit 
along their entire length numerous and filopodia-like protrusions. Whereas the actin 
cytoskeleton in control neuronal cultures was well-defined, antibody-treated neurons show 
abundant protrusions spreading laterally. The phalloidin staining confirms the hypothesis 
that TM-Agrin influences the structuring of the actin cytoskeleton. Those structural 
changes could be observed on axons as well as dendrites. 
 
Discussion 
The transmembrane isoform of agrin is mainly expressed in the CNS and its discovery led 
to the hypothesis that TM-Agrin might be a receptor, involved in signal transduction across 
the membrane, and thus capable of inducing dramatic changes in cytoskeleton. 
As a first step the expression of TM-Agrin was analyzed in non-neuronal cells. The 
striking effect on the shape of transfected cells, compared with non-transfected cells led to 
the question which region might be required for those changes in the cytoskeletal structure. 
Our results suggest that there are two requirements for the capability to induce 
microprocesses. The HSPG agrin is highly glycosylated and exhibits heparan sulphate 
proteoglycan as also chondroitin sulphate side chains which are attached at the protein 
backbone (Winzen et al., 2003). But especially the GAG chain between the 7th and 8th FS 
domain was essential, which indicates the differences between the attached sugar chains. 
However, the presence alone is not sufficient, since SS-NtA-Agrin includes the same 
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glycosylation side and is not able to induce microprocesses (Neumann et al., 2001). Thus, 
the proximity of the GAG chain to the membrane is necessarily required. TM-Agrin has to 
be fixed in the plasma membrane through a transmembrane domain. Interestingly, as it was 
shown above, the TM-domain of agrin could be replaced by that of the asialoglycoprotein-
receptor without any loss of process-inducing activity. Taken together, these results point 
out that TM-Agrin might play a role as co-receptor in cooperation with a signalling 
receptor or that TM-Agrin itself acts a signalling protein. TM-Agrin that is member of the 
large family of HSPGs behaves similarly as syndecans, also a HSPG (Yoneda and 
Couchman, 2003; McQuade et al, 2003). 
In a further step, to analyse expression and function of TM-Agrin, the full-length protein 
was expressed in primary hippocampal neurons. With cTM-Agrin transfected neurons, 
show changes in the elongation and arborization of neurites. Transfected cells form more 
filopodia-like protrusion than controls. 
Since most if not all receptors with a single TM domain can be activated by dimerization 
or oligomerization, independently of the physiological ligand, using polyclonal antibodies 
(Heldin, 1995; Weiss and Schlessinger, 1998), we analyzed potential receptor functions of 
TM-Agrin. Many studies have shown, that oligomerization of receptors can be imitated by 
using bivalent antibodies, so that a signaling cascade can be activated. This system have 
been used for MuSK (Hopf and Hoch, 1998) or TrkA (Clary et al., 1994), adhesion 
molecules (Brieher et al., 1996) or the transmembrane heparansulfate proteoglycan 
syndecan (Carey, 1997). 
In order to study this potential receptor function of TM-Agrin, we incubated non-
transfected primary neurons with anti-mouse agrin antibody. The effect of antibody 
incubation was much stronger, than that observed after transfection. Non-treated neurons 
have a smooth surface and grow straight whereas treated one form numerous protrusions. 
Antibody-treatment seems to mediate oligomerization of TM-Agrin at the surface of the 
cells and as a consequence neuronal cells form actin containing microspikes. These results 
support the hypothesis that the transmembrane isoform of agrin might exhibit signal-
transducing activity that results in reorganization of the actin cytoskeleton. 
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Chapter IV 
Upregulating Utrophin on Muscle Membrane by 
Overexpression of Neural Agrin: an Alternative Strategy 
Introduction 
Duchenne muscular dystrophy (DMD) is a widespread inherited neuromuscular disease 
that results from mutations/deletions in the X-linked dystrophin gene (Gramolini et al., 
1998). DMD is a progressive disease that affects 1 out of 3500 live males at birth (Emery, 
1991). Characteristic is the degeneration of muscle fibers in repetitive cycles. Muscle 
fibers lose the capacity to regenerate, the muscle mass decreases and is progressively 
replaced by adipose and connective tissues. Children affected from DMD become 
wheelchair-bound in early adolescence and die in the second or third decade of life as a 
result of respiratory failure. Dystrophin, a large cytoskeletal protein of the spectrin 
superfamily, connects the extracellular matrix (ECM) with the cytoskeleton of the muscle 
fiber. It binds to a complex of dystrophin-associated proteins (DAP). The absence of 
dystrophin results in disruption of this linkage and thus mechanical damage of the 
sarcolemma during contraction and relaxation. Currently there is no cure, although several 
approaches have been investigated. One alternative consists in using a protein that is 
normally expressed in dystrophic muscle and that can functionally compensate the 
deficiency of dystrophin. Several years ago an autosomal homolog was identified which is 
referred to as utrophin (Love et al., 1989). Utrophin has also the capacity to bind to the 
DAP complex (Matsumura et al., 1992). Thus, utrophin seems to be a good candidate that 
could functionally compensate dystrophin. Several recent studies have indeed shown, using 
transgenic mouse models, that utrophin is able to fulfill this task (Rafael et al., 1998; 
Goudemant et al., 1998; Tinsley et al., 1996). These two proteins have different patterns in 
tissue expression. Dystrophin is mostly expressed in skeletal muscle and in brain. Utrophin 
is widely expressed and present in most organs (Blake et al., 1996). Another significant 
difference is the subcellular localization. Dystrophin is localized extrasynaptically, at the 
cytoplasmic face along the entire length of the muscle fiber. Utrophin in contrast, is 
preferentially localized and concentrated at the NMJ. 
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Fig. 16: Protein interaction in the synaptic cleft and extrasynaptically 
The major components of the basal lamina are collagen IV, laminin, entactin, and heparansulfate proteoglycans (HSPGs). Synaptic and 
extrasynaptic portions of the basal lamina differ in their composition of protein isoforms. 
Dystrophin and its autosomal homolog Utrophin are differ in their subcellular localization. Dystrophin is distributed extrasynaptically on 
the entire length of the muscle fiber wheras utrophin is preferentially expressed in the synaptic region. 
 
It has been postulated that utrophin gene transcription has to be locally regulated within the 
subsynaptic nuclei via nerve-derived trophic factors (Gramolini et al., 1997). Nuclei in 
extrasynaptic regions are also capable of expressing utrophin but only after receiving 
specific neuronal signals. One of these factors that were focused on, was agrin (Gramolini 
et al., 1998). Cultured myotubes were treated with different agrin isoforms. The neural 
isoforms of agrin increases the number of AChR clusters and of postsynaptic 
specializations via activation of the muscle specific tyrosine kinase (MuSK). A gain of 
function experiment showed that microinjection of neural agrin in muscle fibers causes 
ectopic postsynaptic specializations und as a result clustering and concentration of synaptic 
proteins not only at the NMJ (Bezakova et al., 2001). Thus, also the presence of utrophin at 
the cell surface of the muscle fiber was enhanced. Furthermore it was shown that agrin 
treatment not only leads to the redistribution of preexisting molecules, but that it also 
influences and stimulates the de novo synthesis of synapse-specific proteins (Méjat et al., 
2003). 
In this work we took advantage of these mechanisms. The aim was to create a transgenic 
mouse where the agrin expression can be controlled and that can be a model to prevent or 
ameliorate the degeneration of muscle fibers in mdx mice, the murine model of DMD 
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(Tinsley et al., 1996; Deconinck et al., 1997; Tinsley et al., 1998). The upregulation of 
utrophin seems to be a suitable method in the treatment of DMD. 
 
Materials and Methods 
Generating of the Injection Construct 
The injection construct mN25C21B8_myc.pTRE was designed on the basis of 
mN25C9500_myc (unpubl. Ruegg, MA). The sequence encoding mN25C9500 (unpubl. 
Ruegg, MA) was inserted in the TOPO 2.1 vector (Invitrogen) using the restriction sites 
EcoRV and SpeI. A NheI site was inserted by performing a PCR on 
mN25C9500_myc.TOPO with the sense primer sNhe_N25C21(0): 
(5’-CTAGCTAGCGAGAAGGGGATAGTTGAGAAG-3’) 
and the antisense primer asC95_ClaI: 
(5’-CCATCGATGAGAGTGGGGCAGGGTCTTAG-3’). 
By use of the restriction sites NheI and ClaI, the PCR-product was ligated into N25C9500  
The C9500 was now replaced by the shorter C210. In the following step the B8 insert was 
placed in by overlapping PCR. The first PCR was performed on the new obtained 
mN25C210_myc.TOPO by using the sense primer seq.middleNtAFS1_pos.421: 
(5’-GCGGATCACTTTGCGGAACC-3’) 
and the antisense primer as N25C21_B8: 
(5’-TGGGATC TCATTGGTCAGCTCACTCTCAGTCACAGCAT-TG-3’). 
The second PCR-product was made with the sense primer s N25C21_B8: 
(5’-GCTGACCAATGAGATCCCAGCCGAGAAAGCGCTGCAGAGC AAC-3’) 
and the antisense primer asC95_ClaI: 
(5’-CCATCGATGAGAGTGGGGCAGGGTCTTAG-3’). 
The third PCR was done by fusing those two PCR-products and using the sense primer 
seq.middleNtAFS1_pos.421: 
(5’-GCGGATCACTTTGCGGAACC-3’) 
and the antisense primer asC95_ClaI: 
(5’-CCATCGATGAGAGTGGGGCAGGGTCTTAG-3’). 
Using NheI and ClaI sites the new PCR-fragment was inserted into 
mN25C210_myc.TOPO. The new construct is referred to as mN25C21B8_myc.TOPO. To 
be able to express agrin in a TET-off gene expression system, the sequence was cloned into 
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the pTRE vector (BD Biosciences) that contains the TET responsive element (TRE). The 
vector was digested with ClaI, treated with the Klenow enzyme (NEB) and then digested 
with SalI. mN25C21B8_myc.TOPO was cut with EcoRV and SalI and the new agrin 
sequence was ligated into pTRE vector. For injection into mouse oocytes, the construct has 
to be linearized with XhoI and AseI. All constructs were routinely sequenced to eliminate 
the possibility of mutations. 
 
Animals 
The agrin expressing transgenic mouse have been generated as described above. Mice were 
genotyped by PCR using the three following primer pairs: 
1. primer pair: 
sense primer mAgN25C21-s: (5’-CCAATGTGACCGCTAGCGAGAAG-3’) 
antisense primer mAgN25C21-as: (5’-CTGTAGGCCTCCAAGCCACA-3’) 
2. primer pair: 
sense primer seq.ins.B_ms.agrin_pos.5558: (5’- CATGACAATGAGCGTGGCAACC-3’) 
antisense primer asC95_ClaI: (5’-CCATCGATGAGAGTGGGGCAGGGTCTTAG-3’) 
3. primer pair: 
seq.middleNtAFS1_pos.421: (5’-GCGGATCACTTTGCGGAACC-3’) 
sense primer mAgN25C21-s: (5’-CCAATGTGACCGCTAGCGAGAAG-3’) 
PCR was performed for each pair of primer separately. Transgenic lines were identified by 
PCR and Southern blot, and the protein expression was confirmed by immuno-
histochemistry. Positive founders were bred with C57/BL6 mice to keep the lines. As 
negative control we always used wild-type mice C57/BL6. 
 
Preparation and Staining of Crossections 
Soleus was taken out, embedded in tragacant and frozen in liquid nitrogen. Muscles were 
then ready to be cut with the cryostat in 12 µm sections and to put onto slides. After being 
frozen, slides were dried and sections were circled with PapPen. Sections were then 
permeabilized with PBS containing 0.5% Triton X-100, 1% BSA and 2% HoS for 30min at 
RT, and washed twice with wash buffer (0.01% Triton X-100, 1% BSA, 2% HoS in 1 X 
PBS facultative: NaN3). Sections were then incubated oN at 4°C with the primary AB 
(1:2000; rabbit anti-NtA #206) diluted in wash buffer. Sections are next washed three 
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times for 10min with wash buffer, dried and incubated with the secondary AB (1:1000; 
cy3-labeled goat anti-rabbit IgG), diluted in wash buffer. Incubation was for 1h at RT in 
the dark. Slides were washed once more three times 10min with wash buffer, fixed with a 
few drops of EtOH for 2min, dried and then mounted with Citifluor. Before sections can be 
analyzed under the fluorescent microscope they have to be pressed at least 1h at 4°C: 
 
Preparation and Staining of Bundles 
Soleus was taken out and fixed with needles on a plate. It was incubated in PBS and then 
injected with rhodamine-α-bungarotoxin (1:200; Molecular Probes) for 30min at RT. After 
washing with PBS for 30min muscle was injected with 2% PFA and incubated for 10min 
at RT. Bundles were prepared after washing in PBS for 30min at RT. The fixed bundles 
were permeabilized in Falcon in 1% Triton X-100 in PBS for 30min and then blocked with 
100mM glycine in PBS for 30min. Next, bundles were washed and blocked with 1% BSA 
in PBS for 1h at RT and then incubated with the primary AB (1:1000; rabbit Anti-NtA 
#206) oN at 4°C. Washing and incubation with the secondary AB (1:1000; cy3-labeled 
goat anti-rabbit IgG) followed oN at 4°C. Bundles were then mounted with Citifluor after a 
washing procedure of six times one hour. 
 
Results 
Creating a Transgenic Mouse 
Aim was to design a mouse model where agrin transcription can be temporally controlled 
in a TET-off gene expression system. The recombinant mini-agrin construct mN25C21B8 
consists of the N25 N-terminal and the most C-terminal laminin G-like domain, containing 
the B8 insert. This recombinant form of agrin is sufficient for AChR clustering (in vitro: 
Gesemann et al., 1995; in vivo: Meier et al., 1998). It is also sufficient to activate MuSK 
via phosphorylation (dissertation Patrick Scotton). 
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Fig. 17: Domain structure of mN25C21B8 
The injection construct consists of the NtA N-terminus and the most C-terminal localized LG-domain containing the B8 insert. 
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The pTRE vector includes the TET responsive promoter element. First of all we aimed to 
get a transgenic mouse that expresses recombinant agrin. This was examined by immuno-
histochemistry. After injection of the construct, we got 50 founders. 16 of them were 
potentially positive. 7 lines were examined and ectopic clusters were found in the soleus 
muscle of one mouse. This demonstrates that the injected recombinant agrin DNA encodes 
a functional protein. 
From these results we conclude that the mN25C21B8_myc.pTRE mouse can be an 
appropriate model on the way to prevent or to ameliorate muscle degeneration of mdx 
mice. 
 
 
 
Fig. 18: Ectopic clusters  
The whole soleus muscle of the transgenic mice line 1 was stained by α-bugarotoxin (green) and observed with 2.5x objective. As 
shown in A (scale bar: 1 mm), many ectopic clusters of AChRs are formed in the entire muscle, which have the similar size as NMJs. 
Compare to the AChR clusters induced by neural agrin injection (B, scale bar: 100 µm), which are mainly formed in the place close to 
the tendons, the ectopic clusters of AChRs in the transgenic mice are more evenly distributed in the entire muscle. 
 
Discussion 
In this work we demonstrated in vivo that overexpression of the mouse mini-agrin is 
sufficient to induce ectopic AChR clusters, thus provokes postsynaptic differentiation. 
With the increase of clusters also the utrophin level becomes higher. One still unsolved 
question is whether accumulation of AChR clusters is harmful for the muscle fiber. To 
make the system inducible, the next aim is to cross agrin-expressing mice with tTA-mice 
that express tetracycline-controlled transactivator protein (tTA). This protein regulates the 
expression of a target gene, in this case agrin, by binding to TRE. The expression of agrin 
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is downregulated when tetracycline or doxycycline is added. We choose the TET-off 
system because it was shown that it allows an efficient regulation of the transgene both in 
vitro and in vivo (Mizuguchi and Hayakawa, 2002). The system is inducible for the better 
understanding of the mechanisms during muscle fiber degeneration and regeneration. 
Mice that express agrin as well as tTA will be crossbred with mdx mice that suffer from 
muscle degeneration. Agrin overexpression results in utrophin upregulation. So the muscle 
fibers get stabilized and stronger. 
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Chapter V 
General Discussion 
This thesis shows the meaning and importance of agrin in brain and its development and 
also as stabilisator of the muscle fiber. Function of TM-Agrin in the brain was elucidated 
by examining its expression in non-neuronal and neuronal cells. The experiments 
confirmed the hypothesis that TM-Agrin might be strongly involved, in all cell types, in 
the reorganization of the actin cytoskeleton. Transfection resulted in formation of 
protrusion on the cell surface and modifications lead to the hypothesis that agrin promotes 
neurite outgrowth. There is growing evidence that proteoglycans promote neurite 
outgrowth in certain neurons and inhibits it in others. These properties are often connected 
with the GAG chains (Bandtlow and Zimmermann, 2000; Winzen et al., 2003). This is 
consistent with our findings that the GAG chain localized between the 7th and 8th FS 
domain is involved in formation of microprocesses. Expression of different chimera 
constructs in non-neuronal cells elucidated the special function of those GAG chains. The 
precise mechanism is not yet known. In vitro studies have shown that HSPG can support 
neurite outgrowth by activating growth enhancing molecules such as laminin, NCAMs or 
integrins (Martin and Sanes, 1997; Bixby et al., 2002). Moreover, agrin can act as a growth 
factor co-receptor and can so influence axon guidance (Cotman et al., 1999). The role of 
agrin concerning axonal growth and guidance is contradictory as the mechanism of how it 
influences this process is not known. The hypothesis that agrin might act as co-receptor led 
to the analysis of agrin’s function by using antibody-mediated activation by surface 
oligomerization. This mechanism of receptor oligomerization is universal and is found in 
nearly all transmembrane protein with one transmembrane domain (Heldin, 1995; Weiss 
and Schlessinger, 1998). TM-Agrin, a highly glycosylated HSPG has one transmembrane 
domain and so several lines of evidence suggest that the formation of microspikes on 
growing axons was the consequence of an antibody-mediated clustering of TM-agrin. 
Agrin, present on microspikes, induces antibody-mediated clustering of agrin on growing 
axons. In summary, these results support the hypothesis that activation of TM-agrin is able 
to elicit intracellular signaling in neurons and non-neuronal cells, resulting in a 
reorganization of the cytoskeleton and the formation of processes. 
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The multifunctional protein agrin has also an important role in the regulation of the protein 
level of utrophin. Utrophin that is an autosomal homolog of dystrophin, could be able to 
compensate for dystrophin in Duchenne muscular dystrophy where dystrophin is not-
functional. We created a mouse model that expresses mouse mini-agrin and is therefore 
capable to induce ectopic clusters. The agrin transcription will then be negatively 
controlled in a TET-off system. Overexpression of agrin will not only increase cluster 
formation and therefore enhance the utrophin level but it can also induce de novo synthesis 
of utrophin by transcriptional regulation of postsynapse specific genes. This model can be 
a useful means for developing a therapeutic treatment for Duchenne muscular dystrophy. 
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